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Abstract
Cells use a complex web of protein signaling pathways to interpret extracellular
cues and decide and execute cell fates such as survival, apoptosis, differentiation, and
proliferation. Cell decisions can be triggered by subtle, transient signals that are context
specific, making them hard to study by conventional experimental methods. In this
thesis, we use a systems approach combining quantitative experiments with
computational modeling and analysis to understand the regulation of the survival-vs-
death decision. A second goal of this thesis was to develop modeling and analysis
methods that enable study of signals that are transient or at intermediate activation levels.
We addressed the challenge of balancing mechanistic detail and ease of
interpretation in modeling by adapting fuzzy logic to analyze a previously published
experimental dataset characterizing the dynamic behavior of kinase pathways governing
apoptosis in human colon carcinoma cells. Simulations of our fuzzy logic model
recapitulated most features of the data and generated several predictions involving
pathway crosstalk and regulation. Fuzzy logic models are flexible, able to incorporate
qualitative and noisy data, and powerful enough to generate not only quantitative
predictions but also biological insights concerning operation of signaling networks.
To study transient signals in differential-equation based models, we employed
direct Lyapunov exponents (DLEs) to identify phase-space domains of high sensitivity to
initial conditions. These domains delineate regions exhibiting qualitatively different
transient activities that would be indistinguishable using steady-state analysis but which
correspond to different outcomes. We combine DLE analysis of a physicochemical
model of receptor-mediated apoptosis with single cell data obtained by flow cytometry
and FRET-based reporters in live-cell microscopy to classify conditions that alter the
usage of two apoptosis pathways (Type I/II apoptosis). While it is generally thought that
the control point for Type I/II occurs at the level of initiator caspase activation, we find
that Type II cells can be converted to Type I by removal of XIAP, a regulator of effector
caspases. Our study suggests that the classification of cells as Type I or II obscures a
third variable category of cells that are highly sensitive to changes in the concentrations
of key apoptotic network proteins.
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1 Introduction
1.1 Cell Decisions Determined by Receptor-induced Protein Signaling
Networks
1.1.1 Introduction
Cells are confronted with changing environmental signals which they interpret to
decide their own fate - to survive, die, proliferate, migrate, etc. Protein signaling
networks transduce these extracellular cues, process these transient signals in the context
of the current cell state, and effect a change in cell behavior. Because alteration to these
signals can induce major changes in cell behavior leading to disease, many of these
pathways are well studied. Despite the large body of research, a comprehensive
understanding of how cells process signals to arrive at decisions has been elusive because
of the complexity of these networks. This complexity arises because signaling networks
are comprised of intertwined pathways that are each involved in several cell processes
and exhibit cell-type and treatment-dependent behaviors. Understanding the cell decision
process therefore requires a quantitative and multivariate study of the dynamic signaling
response to cues. Mathematical modeling enables these data to be interpreted and
evaluated in the context of the a priori knowledge about the pathways. This chapter
introduces the molecular pathways involved in the death-vs-survival decision in
mammalian cells and current mathematical techniques used to model these pathways.
1.1.2 Apoptosis
Apoptosis, or programmed cell death, is the process through which a cell
methodically self destructs. This process is essential in multicellular organisms for
development and maintenance of healthy tissues. The apoptotic decision is primarily
mediated by two pathways that culminate in an irreversible activation of the caspase
cascade. A key feature of apoptosis is the rapid "all-or-nothing" activation of the
caspases, a family of cysteine proteases. Receptor-mediated apoptosis is typically
characterized by activation of effector caspases which make a binary die-or-survive
decision. The highly regulated signaling pathways involved in this cell decision process
(survival versus apoptosis) are of particular interest because without regulation of the
caspases, cells suffering from genomic instability may survive, potentially leading to
oncogenesis. In cancer and autoimmune diseases, cells erroneously decide to survive; in
degenerative diseases and immunodeficiencies, cells erroneously decide to die [1].
Apoptotic death is deliberate and characterized by altered membrane characteristics,
nuclear condensation, blebbing of the membrane, cytoplasm shrinkage, endonucleolytic
DNA cleavage, and blebbing of the membrane [2].
The intrinsic (or mitochondrial) pathway responds to stress and cues (such as
DNA damage and starvation) and is regulated by the Bcl-2 family of proteins [3-5].
When triggered, the mitochondria outermembrane is permeabilized (MOMP), releasing a
variety of proteins including cytochrome c, Smac/DIABLO, and AIF [6, 7]. Their release
allows the formation of the apoptosome, a complex of procaspase-9, Apaf-1, and
cytochrome c. The apoptosome converts the initiator caspase, caspase-9, to its active
form [8].
The extrinsic, receptor-mediated pathway is initiated through activation of death-
receptor family members (CD95/Fas, TRAIL-R, and TNF-R) by ligand-receptor complex
formation [9-11]. Receptor activation causes formation of a death inducing signaling
complex (DISC) which acts as a scaffold for procaspase-8, an initiator caspase, to
autoactivate by induced proximity [12-14]. MOMP may be stimulated after DISC
formation through truncation and activation of Bid by caspase-8. Positive feedback via
caspase-6 amplifies caspase-8 and caspase-3 activity [15]. Cells have been classified as
Type II if receptor-mediated apoptosis is dependent on MOMP and Type I if cell death is
independent of the mitochondrial pathway [16].
Intrinsic and extrinsic pathways converge at the level of caspase-3 activation by
the initiator caspases (-8 and -9) [17-20]. Caspase-3 is an effector capsase that executes
the cell by cleaving hundreds of protein substrates such as PARP, lamins, and
cytokeratin. Caspase-3 is primarily inhibited by XIAP which acts by binding to active
caspase-3, preventing it from binding its substrates. In addition, XIAP is an ubiquitin
ligase which is thought to tag active caspase-3 for proteasome-mediated degradation,
another mechanism by which XIAP reduces caspase-3 activity. Once released from
mitochondira, Smac/DIABLO binds XIAP, thereby releasing XIAPs inhibition of
caspase-3 shortly after MOMP. Both instrinsic and extrinsic pathways also share several
upstream control mechanisms by kinases such as Akt, ERK, JNK, and IKK [21-35].
-·/
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Figure 1-1 Apoptosis signaling pathway
Two pathways control the activation of the caspases. The intrinsic pathway is mediated by the Bcl-2
family of proteins including Bcl-2, Mcl-1, Bid, and Bax. The Bcl-2 proteins mediate mitochondrial
outermembrane permeabilization (MOMP) and subsequent release of cytochrome c and Smac. The
extrinsic pathway triggers DISC assembly and caspase-8 activation, leading to the activation of caspase-3
which is held in check by XIAP.
1.1.3 Survival
In addition to cellular stresses and death-ligands, the apoptotic decision is
influenced by pro-survival signals stimulated by cytokines such as insulin, IGF, TNF, and
EGF. Several kinase pathways play a central role in transducing signals from these
cytokines. Binding of the ligands to receptor tyrosine kinases induces adaptor proteins
such as IRS-i to effect transient signaling through the canonical ERK, JNK, IKK, p38,
and Akt pathways (Figure 2-1). Significant crosstalk among these pathways motivates
the use of modeling to unify conflicting responses in different cell types to their activities
€.
The most well studied of these is the ERK pathway. ERK is a MAPK, the last
member of a cascade of three kinases. Growth factors and mitogens (EGF and insulin,
for example) lead to activation of a MAPKKK (Raf) after binding to small GTP-binding
proteins. The MAPKKK phosphorylates and activates a MAPKK, MEK, which
subsequently phosphorylates ERK. Once phosphorylated and active, ERK
phosphorylates many substrates including several MKs (MAPK-activated protein
kinases) and transcription factors to promote proliferation and survival [36].
Other MAPKs, p38 and JNK are triggered by stress and cytokines (such as TNF).
Like ERK, p38 and JNK are well studied and have numerous roles in cell decisions [36].
The role of JNK in affecting apoptosis has been debated in the literature - some groups
report that JNK is a pro-apoptotic factor while other report the opposite [37]. These
conflicting reports suggest that JNK's role is highly context specific and motivates a
quantitative, systems-level analysis of these intersecting pathways.
The Akt pathway is strongly induced by prosurvival cytokines, particularly insulin
and IGF, which act through IRS-1 [38-40]. Akt is a serine/threonine kinase whose
activity is regulated by PI3-kinase (PI3-k). Akt interacts with many signaling pathways
including those regulating IKK, JNK, mTOR, FKHR, and ERK to control both cellular
metabolism and survival. Though controversial, Akt may also exert anti-apoptotic
influence by phosphorylating Bad, thus blocking its ability to competitively bind pro-
survival Bcl-2 and Bcl-xL [41].
IKK activation is strongly induced by TNF and DNA damage. When active, IKK
phosphorylates IKB. In the phosphorylated state, IKB is tagged for ubiquitination and
subsequent degradation, releasing NF-kB which it normally binds and sequesters in the
cytoplasm, and enabling it to relocate to the nucleus [42]. NF-kB is a transcription factor
that is both pro-inflammatory and pro-survival; it induces changes in gene expression for
key proteins such as the anti-apoptotic factor XIAP.
TNF EGF insulin
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Figure 1-2 Pro-survival signaling pathway
Cytokines such as TNF, EGF, and insulin stimulate the activation of pro-survival (and pro-apoptotic)
pathways. These pathways are highly interconnected making it difficult to delineate the role of each
pathway in the death-vs-survival decision. This diagram was adapted from [43].
1.2 Modeling/analysis approaches and challenges'
1.2.1 Introduction
Molecular, cellular and developmental biology seek to describe physiological
processes in terms of biochemical pathways and molecular mechanism. Medicine and
drug discovery add the practical goals of understanding disease and developing therapies.
Molecular biology has been dominated by attempts to identify key gene products,
characterize their loss-of-function phenotypes, and determine their biochemical activities.
Genomics does not in and of itself spell an end to this "component identification" phase
of modern biology, but the sheer size of the cellular parts list emphasizes the need to
' This section contains excerpts and figures from 44. Aldridge, B.B., et al., Physicochemical modelling of
cell signalling pathways. Nat Cell Biol, 2006. 8(11): p. 1195-203.
understand genes, disease and pharmaceutical agents quantitatively in terms of pathways
and circuits. Much has been written about the limitations of "common sense thinking" as
a means to understand the complexity of biological pathways and about the need for
integrative approaches such as mathematical modeling [45]. Modeling that builds on
empirical data to construct chemically and physically realistic representations of
biological pathways has the ability to elucidate molecular and system-wide mechanism,
systematize diverse experimental data and generate specific, testable hypothesis.
1.2.2 Physicochemical modeling
Physicochemical modeling combines prior knowledge about cell signaling and
regulatory pathways with fundamental principles derived from chemistry and physics to
create a powerful tool for formalizing and extending traditional approaches to molecular
biology approaches. Physicochemical modeling is a natural counterpart to molecular
experimentation and is an extension of the current practice of drawing pathway maps,
albeit one with much greater rigor and power. Accurate physicochemical models of
cellular pathways aim to explain molecular mechanism in the context of upstream and
downstream regulators, reveal pathway design principals and serve as dynamic
repositories of data and knowledge.
Physicochemical modeling seeks to describe properties such as covalent
modification, intermolecular association, and intracellular localizations, of biomolecules
in terms of equations derived from established physical and chemical theory [46-50]. The
power of physicochemical modeling lies in its ability to encapsulate prior knowledge and
make specific predictions. Physicochemical modeling works best with pathways in which
components and connectivity are relatively well established. When prior knowledge is
sparse, data-driven statistical models are generally more appropriate [51]. Equations in
physicochemical models refer to identifiable entities and parameters have chemical
meaning (concentration, binding affinity, rate of reaction etc). A physicochemical model
can therefore be viewed as a mathematical translation of a pathway map, and, thus, as a
logical extension of current practice. Moreover, adoption of recently developed
schematic standards for pathway mapping should help the translation process [52].
The correct mathematical form for a physicochemical model depends on the
properties of the system under study and the goals of the modeling effort. Ordinary and
partial differential equations (ODEs and PDEs) are used most commonly and both can be
cast in either deterministic or stochastic forms. Deterministic differential equations are
continuous in time (or time and space) whereas stochastic differential equations are
discrete and include effects arising from random fluctuation around the mean behavior.
Currently, the most common means of representing biochemical pathways is via a set of
coupled deterministic ODEs. Coupled sets of ODEs (ODE networks) cast mass action
kinetics in terms of the rates of production and consumption of individual biomolecular
species (d[Xi]/dt). Provided that reasonable values for the initial concentrations of species
can be obtained (the initial conditions), time integration of ODEs yields the
concentrations of each species at any subsequent point in time, thereby facilitating
comparison of the model to experimental data. ODE networks are amenable to a wide
variety of analytic techniques, some of which are difficult if not impossible with more
complex mathematical forms.
In an ODE network, each biochemical transformation is an elementary reaction
with forward and reverse rate constants (Figure 1-3). Changes in localization, a central
feature of biological pathways, are represented by compartmentalization. Each species is
allowed to inhabit one or more compartments and to move among the compartments via
elementary reactions. Compartments are also used to represent assembly of
macromolecular complexes and other changes of state not usually associated with
enzymatic action. Two fundamental assumptions of the compartmentalized ODE
formalism are that, within a compartment, the concentration of each species is high and
uniform such that transport is essentially instantaneous (that is, the compartment is well-
mixed). Between compartments, transport is slower and is therefore associated with an
observable rate. If these assumptions are not satisfied, then it is necessary to model
explicitly changes in species concentrations with respect to space (typically using PDEs).
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Figure 1-3 Steps in physicochemical modeling
Current Practice - Pictograms: A pictogram is a highly abstracted representation depicting components of a
pathway and their interaction. Here, a simple linear Ligand-Receptor-Kinase-Substrate pathway is
depicted. While the pictogram nicely conveys the general information flow in the network, mechanistic
details required for mathematical modeling is absent.
Formal Pathway Diagram: A pathway diagram drawn with CellDesigner details the reaction network [53].
Instead of representing the kinase as one object (as in the pictogram), each form of the kinase, either in
complex or alone, must be depicted (K, K*, LR*K, and K*S). A key challenge in developing a pathway
diagram is making choices about granularity in species and reactions. In this example, the receptor is a
dimer and each subunit has two phosphorylation sites, yielding 64 possible ligand-receptor dimer
complexes. However, this complexity is represented simply by two species: non-active and
unphosphorylated (R) and ligand-bound, fully phosphorylated (LR*). It should be noted that approaches
such as rules-based modeling may be preferred to the use of pathway diagrams (see text for details)
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Reaction List: A complete list of reactions is generated based from the pathway diagram. This list can be
automatically produced with several specialized software tools [54]. For reversible reactions, both forward
and backward rate constants must be indicated.
Differential Equations: From the list of reactions, a system of differential equations can be enumerated
using appropriate rate laws. A highly effective basis for rate laws is mass-action kinetics, which uses the
product of a rate constant and the concentrations of the reactants to calculate the rate of formation of
product and elimination of reactants (in the continuum approximation).
Simplifying Assumptions: Simplifying assumptions can be made to reduce the complexity or size of a
model. The Michaelis-Menten approximation to enzyme-substrate kinetics is often applied. This particular
rate form assumes rapid equilibrium of an intermediate complex (K*S), so a quasi-steady-state
approximation is imposed (d[K*S]/dt=-0O), thus reducing the number of species in the model. Because this is
an approximation to mass-action kinetics, its use can alter model behavior, particularly when the
intermediate complex does not reach equilibrium or the reaction is tightly coupled to other processes [55-
57].
1.2.3 Graph-based modeling
Mechanistic, ODE-based models cannot be used when the knowledge describing
molecular mechanisms are not well defined. Instead, other modeling techniques ranging
from projection methods to statistical and logic-based models may be applied. These
methods, while more abstract than physicochemical modeling, can be well-suited for
straightforward interpretation and incorporation of granular data. The choice of modeling
method depends on the level of quantitation of the experiment data, prior knowledge of
the pathways under study, and types of questions posed. Data projection methods such as
principal component analysis (PCA) and partial least-squares regression (PLSR) are the
most abstract and are especially useful for linking signaling factors to different cell
responses. These methods cannot incorporate prior knowledge about the signaling
pathways, except for helping the modeler design which signaling metric (normalization,
integration, peak intensity, etc) to include in the analysis. A recent set of studies using
PCA and PLSR modeling on a data-compendium detailing the signaling and apoptotic
response the EGF, TNF, and insulin in human colon carcinoma cells has established
standards for data normalization and identified novel autocrine and pro-survival signaling
events [43, 58, 59].
Graph-based models using Bayesian and Boolean logic networks have been used
to quantify signaling species interactions to each other and to phenotypic response [60,
61]. Bayesian networks and dynamic Bayesian networks (Markov models) are used as a
reverse engineering approach to quantify the strength of influence among signals using
Bayesian statistics. These models have the advantage that they can be easily derived
from data to identify candidate network topologies, though this process requires a dataset
rich in perturbations to individual network species. Because Bayesian models are
constrained to be acyclic, a major disadvantage of these models is their inability to
encode positive and negative feedback. To find cycles, it may be possible to compile an
ensemble of high-ranking acyclic models.
Like Bayesian networks, Boolean logic models use an edge-node graph
representation where each edge carries signals to nodes, which specify the activity or
concentration of a network species given the state of the input signals. In Boolean logic,
signals are classified as being either low or high (at edges) and logic gates define the
interactions between the input and output signals (at nodes). Because these rules can be
written as if-else statements, they are intuitive to read and write, making logic-based
methodology attractive for modeling protein signaling networks, which are often depicted
as graphs with arrows marked as being either activating or inhibitory. Due to the
simplified formalism, Boolean logic models can be built gradually and can therefore
incorporate a priori knowledge, hypothesis, and experimental data about network
topology and species interactions. Logic-based models are simple to build, manipulate,
and interpret, making them appealing because they don't require specific computational
or mathematical skills. However, these advantages are counter-balanced by the abstract
representations of molecular interactions and dynamics in signaling as compared to
physicochemical modeling. Both Boolean logic and Bayesian models discretize
biological information (protein concentration, state, or activity) which is often inherently
continuous. Using multi-step discretization may mitigate the loss of information from a
two-step discretization, and their ability to capture dynamic and intermediate signaling
events as compared to continuous methods has yet to be comprehensively addressed.
1.3 Challenges in combining models and experiments 2
1.3.1 Introduction
To quantitatively understand signaling networks, an iterative approach of
mathematical modeling and experimental measurement is required [62]. It remains
challenging to construct models that represent real biological pathways and to establish
rigorous links between models and experimental data: in many cases, the underlying
experimental data are simply too incomplete. Current challenges in building pathway
models include more efficient and transparent ways to summarize prior knowledge, fit
parameters, specify model structure, and analyze models.
1.3.2 Model construction
The construction and calibration of biochemical pathway models will continue to
generate controversy among both physical scientists and traditional molecular biologists.
It is often presumed that complex models have sufficient degrees of freedom to fit any
piece of data. In the oft-misquoted perspective of Gauss "Give me four parameters, and I
2 This section contains excerpts and figures from 44. Aldridge, B.B., et al., Physicochemical modelling of
cell signalling pathways. Nat Cell Biol, 2006. 8(11): p. 1195-203.
will draw an elephant for you; with five I will have him raise and lower his trunk and his
tail" [63]. Clearly models should be formulated with as few species and free parameters
as possible. However, if model granularity is too low to make predictions at the level of
individual gene products, molecular biology, pharmacology, and genetics are less useful
in model verification. Pathway models in biology therefore represent a compromise
between excessive complexity and too many degrees of freedom and excessive
simplification and loss of mechanistic insight. As with mesoscale engineering models,
biological models are likely to become hybrids with varying levels of detail. This will
most likely involve a merger of differential equations with logic based approaches.
Assuming that a model with correct components and connectivity has been
constructed, the next critical step is determining the values of variables including rate
constants and initial conditions (concentrations at time=0). Variables can be measured
directly (or obtained from the literature) particularly in the case of protein and mRNA
concentrations. Rate constants can also be measured in vitro, although it is often unclear
how these rates compare to rates in cells. It is common however, for many parameters in
biological models to remain unmeasured and to therefore require estimation. This is
accomplished by fitting the model to data in via regression. That is, even if the value of
particular parameter cannot be measured directly or, derived independently it can be
estimated by computing the range of values over which the model most closely matches
experimental observation, given uncertainty in the data.
The difficulty and reliability of model regression is closely tied to the number of
free parameters and to the amount and quality of training data. Models of intracellular
pathways typically have large numbers of free parameters that must be estimated using
noisy, incomplete data. In the noise-free case, 2n+1 observations are needed to estimate n
parameters in an ODE model, but the presence of noise makes regression more complex
[64]. Regression with noisy data proceeds via a series of statistical tests whose power is
proportional to the amount of data and inversely proportional to the noise. For each
parameter, model calibration has the potential to yield correct values, incorrect values and
weakly determined values. By weakly determined we mean that the variable can take on
a wide range of values without altering the goodness of fit to observation. In these cases,
it is often assumed that the model is "robust" to changes in the parameter. However,
parameters in large models can be tightly coupled so that uncertainly in some parameters
can affect all parameters. Thus, unconstrained parameters are correctly regarded as ones
about which modeling and experiment provide little insight.
Two critical decisions in the design of models are specifying the scope and level
of detail. As a practical matter, models must concentrate on a small subset of the totality
of reactions that take place in a cell (Figure 1-3). Thus, assumptions must be made about
the extent to which species included in the model evolve independently from species
excluded from the model. The issue of model scope is usually cast in terms of modules -
subsets of cellular reactions assumed to work together in the execution of discrete
physiological functions [65]. Models published to date are relatively limited in scope and
their size is typically set by prior practice in the field or by the availability of
experimental reagents. Little exists in the way of rigorous theoretical or empirical
evidence for modularity in cell signaling pathways, but it is an assumption implicit in all
molecular approaches, not just physicochemical modeling. Indeed, uncertainty as to the
components, connectivity and properties of a pathway is a key motivation for undertaking
rigorous, quantitative modeling. For the foreseeable future ad hoc assumptions are likely
to determine the scope of most models. However, as models grow in complexity and
size, and as understanding of network architecture increases, we can expect much greater
insight into modularity.
A second design decision in assembling a model is the degree of detail (that is,
model granularity). It is not possible to derive the functional properties of proteins and
other biomolecules directly from their chemical structures and pathway models are
therefore not detailed molecule-level representations. Conversely, relatively little insight
is obtained when molecular processes are lumped together to produce few species and
equations. Physicochemical modeling, for example, aims to make experimentally testable
predictions at the levels of genes and proteins, and this therefore determines their
granularity. Pathway models are therefore mesoscale models in which the number of
species is similar to the number of unique gene products.
The correct granularity for pathway models is complicated by the fact that
proteins assemble into large multi-component complexes, undergo extensive post-
translational modification and partition among multiple cellular compartments. If these
processes are to be represented in a model, the number of species increases dramatically
relative to the number of gene products. In the case of the epidermal growth factor
receptor (EGFR), a membrane-bound receptor tyrosine kinase that forms dimers with one
of three other family members, 276 distinct homodimeric species can arise from three
binding partners and two phospho-forms ([66]; actually EGFR has more than eight
binding partners and ten phosphorylation sites, 10). The "combinatorial explosion" in
biochemical species relative to gene products represents a formidable problem for model
generation and analysis, topics that have recently been discussed in detail [67]. It is
therefore common to limit models to a subset of possible species. If data are available
demonstrating the equivalence of biochemical forms then lumping them together is
clearly warranted. Similarly, if assembly or multi-site modification is rapid and
processive, then intermediate states can be ignored. In some situations, including EGFR
signaling, the significance of different biochemical states is not known and the level of
detail that yields the most accurate model remains unknown.
The multiplicity of biochemical species arising from processes such as receptor
activation argues in favor of models with many species. However, the larger the number
of species and free parameters, the greater the arbitrary adjustability of a model, and the
greater the chance that parameters will be indeterminable. In the absence of
countervailing evidence, the best model is the one that is most parsimonious in species
and parameters. Thus, a balance must be struck between too few species and insufficient
molecular detail and too many species and model indeterminability. Even in highly
granular physicochemical models it is rarely necessary to include detailed representations
of core metabolic and synthetic processes such as protein synthesis, energy production,
gene transcription etc. Instead, these processes can be introduced as simplified "lumped"
rates. Metabolic and synthetic processes are themselves being subjected to quantitative
modeling and hybrid models will therefore develop in which biological processes are
alternately modeled in detail or in aggregate. For example, a highly simplified "lumped
rate" representation of a detailed synthesis model could be embedded in a
physicochemical model of signal transduction to yield a hybrid. Realistic regulation could
be reproduced by including an adjustable parameter in the lumped reaction that makes
translation dependent on signal levels; in the hybrid model, it is not necessary to include
the synthesis model in its entirety.
The issue of model granularity also arises in formulating equations that represent
elementary reactions. For example when a reaction is very fast as compared to other
reactions (by a factor of> 100x), it can be assumed that the fast process operates in quasi-
equilibrium. A combination of fast processes can also be assumed to operate at quasi-
steady-state. Differential equations can then be substituted by time-independent algebraic
relations [68, 69]. The result is a model with fewer species, equations and parameters but
more complex rate terms. A specific and common example of algebraic substitution is
replacement of mass-action kinetics with Michaelis-Menten kinetics. In this case,
differential equations representing enzyme-substrate intermediates are substituted by
differential algebraic equations slightly more complex than an ODE in mathematical
form but with fewer free parameters (Figure 1-3). A second example of algebraic
substitution involves representing a series of reactions as a "transfer function" in which
inputs (such as the concentrations of substrates) are translated into outputs (rate of
formation of a product) via an assumed or fitted algebraic function. A common example
of a biological transfer function is a Hill function (itself derived from the Michaelis-
Menten equation), which captures the cooperative behavior of an enzyme cascade or
protein multimerizatioin in a single exponential function with an adjustable Hill
coefficient [46, 70]. Substitution of ODEs by transfer functions and other algebraic terms
constitutes a very simple example of model order reduction [71]. However, in all model
order reductions it is important to ascertain whether the implied assumptions are valid. It
is not always appreciated, for example, that Michaelis-Menten kinetics represents a
simplification of mass action kinetics valid in the quasi-steady-state, but not necessarily
in the case of rapidly evolving reactions. [55-57].
Once a preliminary model has been constructed it must be subjected to
verification, calibration and validation. Verification is the process of determining how
accurately prior knowledge and underlying assumptions have been translated into
mathematical form (that is, whether the model structure is correct [72, 73]). Calibration
(also known as regression or training) is the process by which parameters in a model are
estimated so that the model matches experimental data. Finally, model validation is the
process of evaluating the match between model performance and the primary design goal.
In the case of biological models, this is usually a close match between model and
experimental data. Robustness and bistability are sometimes introduced as additional
validation criteria; but their relevance as general constraints on model behavior is not
clear.
Most physicochemical models, particularly those of eukaryotic networks, await
rigorous regression, and parameter values are therefore largely unconstrained. A useful
starting assumption is to set parameter values within physically plausible ranges and
conservative catalytic rates, which for physicochemical models are kf -10-6 (number/cell)"
1 sec- , kr ~10-2 to 10-3 sec-', kcat -1-10 sec-', Kd (for complexes) -108-M and
concentrations in the range of 103 to 106 molecules per 10-12 L cell. Uncalibrated or partly
calibrated models are useful for simulating results but definitive conclusions cannot be
drawn about the rates of specific reactions. In addition, different models, or models with
the same structures but regressed against different sets of data, cannot be rigorously
compared. The quality of calibration is also related to the issue of model uniqueness. That
is, is a particular model structure and set of parameter values the only way to model the
data? Unfortunately this is typically a very difficult question to answer conclusively [62].
The extent to which incomplete calibration is a serious issue depends critically on the
hypotheses one hopes to derive from the model.
1.3.3 Model Analysis
Physicochemical models of biological pathways are attractive because the
mathematics provides a means to merge prior knowledge with experimental data and
underlying physical principles. Pathway models make it possible to examine in detail the
effects of protein dysregulation and pharmacological intervention. Formal analysis of
pathways should also help to uncover design features and common motifs as well as
reveal the extent to which pathways are truly modular. An additional, and less
appreciated aspect of models is their ability to serve as transmittable repositories of
knowledge.
Once model structure is set and initial conditions and rates have been determined
or estimated, mathematical exploration and analysis can begin. Simulation is a simple
but powerful tool for exploring network behavior and for guiding experimental
verification. With little effort, time-dependent concentrations of key species can be
compared over a range of protein concentrations, network topologies, and rate
parameters. To simulate the effects of RNAi, for example, a model is run with new,
experimentally-derived, concentrations for the depleted protein. To simulate the effects
of a kinase inhibitor, the catalytic rate constant or level of bound ATP are reduced. In
each case, simulated data can be compared to data such as flow-cytometry, quantitative
Western blotting and time-lapse microscopy. For example, six models with different
structures for Mdm2-p53 interaction were recently compared to live-cell imaging data so
as to select the best model [74]. An interesting aspect of this work was the inclusion of
experimental noise in the simulated data so as to facilitate comparison to real data.
Sensitivity analysis is a powerful method for systematically determining which
concentrations and rate constants (or other parameters) in a model influence overall
behavior (Figure 1-4). Insensitivity of a model to parameter variation has been equated
with robustness, but robustness is probably better defined with respect to the sensitivity
of network behavior to noise, either in the experimental data or in stochastic reactions (in
product engineering, robustness in design involves searching the space of adjustable
parameters for values that minimize the influence of noise system behavior [75]; Figure
1-4). Both the objective functions (such as maximum integrated output, rate of change of
output etc) and the set of variables over which the sensitivity analysis is performed can be
defined, as can the range of values to be evaluated. Because the objective function is
typically sensitive to changes in multiple parameters, multidimensional sensitivity
analysis is the preferred approach [44, 76, 77]. Sensitivity is often visualized as a
landscape of "hills" and "valleys" representing areas of parameter space in which small
changes have a significant effect on behavior. In addition to revealing key parameters in
a network, sensitivity analysis is valuable in ascertaining which parameters should be the
focus of direct measurement or where perturbations of the system will be most
informative.
A second approach to analyzing physicochemical models is qualitative and based
on determining the classes of behavior it can produce, such as bistability, oscillation etc.
Sets of differential equations can be solved for their stable and unstable steady states (that
is, sets of parameter values at which the model does or does not return to the steady state
upon perturbation) by setting the rate of change to zero (representing the steady state).
Bifurcation analysis makes it possible to determine whether different trajectories through
parameter space lead to different qualitative behaviors about the steady-state. However,
in the case of transient processes typical of cell signaling and regulatory pathways,
techniques from dynamical systems theory need to be adapted to physicochemical
models. These methods will need to determine, without looking at steady-state behavior,
how the output of a model will change over time (or time and space) when initial
conditions or parameter values change.
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Figure 1-4 Sensitivity analysis and parameter estimation
Parameter estimation: Parameter estimation uses an objective function to optimize parameter sets, with the
goal of fitting model to data. The results of parameter estimation are context specific (dependent on time,
the parameters of the model, and the objective function) and many methods exist (such as Monte Carlo
simulations) to ensure that the estimation does not end in a local minimum of the objective function [78].
The shape of minimum is reflection of parameter sensitivity - long, thin valleys are sensitive to some, but
not all parameters.
Sensitivity analysis: The relative importance of the various network species and reactions can be
investigated by using sensitivity analysis. This analysis is frequently performed in terms of individual
parameter (rate constants or initial concentrations) changes. However, sensitivity is context-specific, and
calculating sensitivity while multiple parameter change simultaneously provides a more global view of
network behavior. A challenge lies in choosing appropriate objective function and parameters for
evaluation analyze. Typically, a sensitivity objective function is d[one parameter]/d[another parameter]
evaluated at a finite time, or integrated over time.
As one example, consider the last step in the apoptosis decision network: prolonged activation of caspase-3(c3) resulting in degradation of key cellular components. In receptor-mediated apoptosis, caspase-8 is
activated by a death receptor. Positive feedback is achieved by a caspase cascade (caspase-8 (c8) and
caspase-3 activating each other). Caspase-3 activation (c3*) is inhibited by binding and ubiquitination by
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X-linked inhibitor of apoptosis (XIAP). This small pathway and model is specified in detail in Chapter 3
and [77]. Parameter estimation can help identify the best fit parameters according to an objective function
(fobj), such as the least squared difference between the model and experimental data. As with sensitivity
analysis, parameter estimation can elucidate which parameters should be measured experimentally (here,
more care is required in measuring kd6 than kl). Multiple parameter sensitivity (illustrated here as finite-
time Lyapunov exponents, see Chapter 2) is highest in the phase-space region separating life or death
signals - accordingly, this region (blue) is called a separatrix (see Chapter 3). We observe that the
separatrix is invariant to the initial amount of inactive caspase-8, but not the active form or XIAP. The
critical amount of caspase-8 or XIAP needed to alter behavior is dependent on the initial conditions of the
other network species. Individual parameter sensitivity analysis was performed from three different
locales of phase-space: low, medium, and high initial concentrations of XIAP (red, gray, and green,
respectively). Sensitivity is measured as d[active c3]/d[parameter] at six hours after simulating a spike of
caspase-8 activation. The system is most sensitive to caspase-8, XIAP, and the rate constant involved in
the ubiquitination of caspase-3 by XIAP. As expected, single parameter sensitivity is most remarkable
when calculated at a medium level of XIAP, lying on the separatrix.
1.4 Thesis Aims
This thesis focuses on combining mathematical modeling and experimental data
to better understand how cancer cells arrive at a cell death decision. My particular
interest was in developing new modeling and analysis methodologies that help us more
effectively derive new understanding from experimental data and also drive the design of
new experiments. Chapter 2 describes an improvement to discrete, logic-based modeling
methods by using fuzzy logic to model a dataset characterizing the signaling response to
conflicting pro-death and pro-survival cytokines. Chapters 3 and 4 focus on the apoptotic
decision in the context of a single death ligand. In Chapter 3, a novel analysis
methodology is described to analyze transient signaling in physicochemical modeling. It
is based on direct Lyapunov exponents and applied to a small model describing caspase-3
activation. In Chapter 4, a model of TRAIL-induced apoptosis is analyzed using
Lyapunov exponents with the goal of characterizing conditions leading to Type I vs Type
II apoptosis. The analysis predicts that the ratio of XIAP to caspase-3 can influence
which pathway is used in the apoptotic decision; we confirm this hypothesis
experimentally.

2 Fuzzy Logic Analysis of Pathway Crosstalk in
TNF/EGF/Insulin Signaling
2.1 Introduction
A variety of modeling methods can be applied to understanding protein signaling
networks and the links between signals and phenotypes [51]. The choice of modeling
method depends on the questions being posed (e.g. mechanistic or phenotypic), the
quality and type of experimental data (quantitative or qualitative), and the state of prior
knowledge about the network (interaction map or detailed biochemical pathway; Figure
2-1). Abstract techniques are largely data-driven and aim to discover correlations among
signals and between signals and cellular phenotypes [51]; these methods include principal
component analysis (PCA) and partial least-squares regression (PLSR). Differential
equation-based models, in contrast, are highly specified and dependent on extensive prior
knowledge of components and their interactions, but have the advantage that they capture
temporal and spatial dynamics at the level of individual reactions [44]. Between these
extremes, modeling methods such as Bayesian statistics, hidden Markov models, and
logic-based models have been used to construct graph-based representations of influences
and dependencies among signals and phenotypes based on experimental data [60, 79-83].
An advantage of these methods is their applicability to situations in which mechanistic
information is incomplete or fragmentary but the notion of a pathway or network of
interacting species nonetheless informative. Moreover, logic-based models use natural
language to encode common logical statements such as "if the kinase is not active or the
phosphatase is overexpressed, the substrate is not phosphorylated". Logic-based models
are commonly depicted as edge-node graphs in which interactions among species occur at
nodes, with gates specifying the logic of the interactions based on a set of specified rules.
The identities of the gates are typically determined based on prior knowledge or
experimental observables and the input-output relationships of each gate inferred from
experimental data [61, 82-87].
Among logic-based methods, Boolean modeling is the most common. For
example, a discrete-state representation of the phosphorylation of insulin receptor
substrate 1 (IRS-1) at serine 636 (IRS(S)) might use three input edges for time, TNF and
EGF (see below), one output edge for IRS(S), and one logic gate (Figure 2-2A). In
Boolean logic, the interactions among these inputs involves a combination of elementary
"AND", "OR", and "NOT" gates that connect to create logic such as "(EGF OR TNF)
AND (NOT(time))" that is most conveniently specified by truth tables (Figure 2-2B-C).
Truth tables consist of lookup values for the outputs (consequent value) based on all
possible combinations of input values (antecedents; 1 for on and 0 for off). Despite the
appeal of Boolean models as a simple way to encode interactions among species, the two-
state "on-off' representation of biological signals is unrealistic [88]. In this chapter we
propose fuzzy logic (FL) as an approach to logic-based modeling with the simplicity of
Boolean approaches but with several significant advantages [89], among which the ability
to encode intermediate values for inputs and outputs is the most important. FL can
encode probabilistic and dynamic transitions between network states so as to create
realistic and easy to understand depictions of cell signaling networks [61, 85-87, 90-92].
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Modeling techniques balance specificity and complexity. Principal component analysis elucidates
correlations among network components (A-E) by a linear transformation of the data, resulting in
orthogonal principal components. Bayesian networks use conditional probabilities to associate correlations
and influences between network components. Fuzzy logic uses rule-based gates and probabilistic
representation of input variables to quantify influences and mechanism that regulate network species.
Differential-equations models using mass-action kinetics are highly specified defining regulatory
mechanism by defining rates of change in network species concentrations.
The death-survival decisions in mammalian cells that are examined in this chapter
are mediated by the joint action of multiple receptor-dependent and cell-intrinsic
processes that coordinate opposing pro- and anti-apoptotic signals. We have previously
described a "cue-signal-response" (CSR) compendium of protein signals and phenotypic
responses in HT-29 human colon carcinoma cells treated with combinations of tumor
necrosis factor-ce (TNF), epidermal growth factor (EGF), and insulin [58]. The
compendium includes ten measurements of protein modification states (phosphorylation
and cleavage) and kinase activities for four proteins downstream of TNF, EGF and
insulin receptors collected over a 24 hr time period in biological triplicate (see Figure 2-
4A and Figure 2-5A). To date we have used PLSR to predict the phenotypic
consequence of perturbing the signaling network [43] and PCA to identify autocrine
feedback circuits [59]. Here we ask whether the application of FL to this data can
accurately encode important aspects of network dynamics. We also compare FL and
Boolean models directly and observe a superior fit by the former to data. Finally, we use
our FL model to generate predictions concerning mechanisms of mitogen-activated
protein kinase-activated protein kinase 2 (MK2) activation and regulation of IkB kinase
(IKK) by EGF.
2.2 Results
To assemble a FL model, we first determined local interactions in the network
with FL gates based on relationships among particular subsets of the signals based on
prior knowledge of which signals regulate the activities of others. This was accomplished
using an adaptation of the FL toolbox in Matlab. Once gates were determined, we
constructed a global model by connecting the FL gates together. We analyzed the
behavior of the global model in terms of the overall dynamics of signaling proteins under
various combinations of stimulation by TNF, EGF, and insulin.
Working with FL models involves manipulating logic gates based on several
adjustable parameters: (i) Membership functions (MFs) are used to map the values
appearing at inputs to membership in a pre-specified input state (such as "low",
"medium", and "high"). (ii) Degree of membership (DOM) is the quantification of the
mapping of inputs to MFs and is always between 0 (no membership) and 1 (full
membership). Fuzzy logic is so-named because inputs can have non-zero DOM in
different MFs, unlike discrete-state logic in which MFs and DOMs only takes on the
values 0 or 1 [89, 93]. Figure 2-2D illustrates example MFs for Boolean and fuzzy logic
models. (iii) Once the logic rules are established, a FL gate is generated by firstfuzzifying
the inputs, a step that computes the DOM of each input state over the current input values
and the pre-specified MFs. (iv) The degree offiring (DOF), then quantifies whether a rule
should be used (1) or not (0) as determined from the lowest DOM amongst the
antecedents and the rule weight, a value between 0 and 1 that allows additional tuning of
a rule's importance. (v) In contrast to Boolean logic (BL) gates in which only one rule
can fire for any set of input values (that is, only one row in the truth table is applied), FL
gates allow multiple rules to fire to varying degrees (defined by the DOF).
Defuzzification is a final step in which the superposition of multiple rules is resolved to
determine the output value for the gate. Because of this flexibility, FL can model
intermediate levels of activity using a network similar in structure to a purely "on-off"
BL network (Figure 2-2E).
2.2.1 Data for simulation
Gates for the CSR dataset were constructed by inference working from a
normalized heat map of the 0-24 hr data and a network diagram, both adapted from the
work of Gaudet and Janes et al. (Figures 2-3, 2-4, and 2-5) [43, 58]. FL gates were
constructed to represent the responses of signals such as phosphorylation, activation, or
total levels of MK2, c-jun N-terminal kinase (JNK), extracellular signal-regulated kinase
(ERK), Akt, IKK, Forkhead transcription factor (FKHR), mitogen-activated protein
kinase kinase (MEK), IRS-1, cleaved caspase-8 (Casp8), and pro-caspase-3 (ProC3) to
cues corresponding to TNF, EGF, or insulin treatment (Figure 2-3, Figure 2-4B). The
first five measurements characterize central nodes in five canonical kinase pathways
governing epithelial cell death; FKHR is a transcription factor downstream of Akt, MEK
is a kinase directly upstream of ERK, IRS(S) and IRS(Y) represent modifications of
insulin receptor substrate (IRS) by insulin receptor, and cleaved-caspase-8 is the active
form of the initiator caspase that cleaves caspase-3, an effector caspase responsible for
degrading essential cellular proteins, activating CAD nucleases and killing cells.
2.2.2 Assembling a fuzzy logic gate
To illustrate the method by which FL was adapted to model control of an
intracellular signaling protein, consider a gate describing control of IRS-1
phosphorylation at serine 636 (IRS(S)) by EGF and TNF (Figure 2-2F-H). For IRS(S),
the inputs were TNF concentration, EGF concentration, and time, and the output was the
level of IRS(S) phosphorylation. Time was explicitly included as an input to model
dynamics and rates. Membership functions were defined to relate input values to the
DOM for each input state. For IRS(S), the EGF input variable has low (L) and high (H)
states (Figure 2-2F). When normalized EGF activity was -0, there was a high (-1)
DOM to L and low (-0) DOM to H. As the EGF activity increases to 0.5, DOM=0.5 for
both L and H. Output variable levels were treated as constants (see Figure 2-2F and
Section 2.4); MFs were unnecessary here because gradation of the output is obtained
during defuzzification (see below). Once the membership functions were defined, the
logic rules were listed as "if A (the antecedent), then B (the consequent)" statements
using the inputs and output states as descriptors; e.g., rule 2: if TNF is H and time is L
then IRS(S) is H (Figure 2-2F). Each rule had an associated weight factor between 0 and
1, which could be used to quantitatively represent the relative importance of the rules.
The input and output activities were normalized between 0 and 1 for simplicity.
For example, in the IRS(S) gate, TNF concentrations of 0, 5, and 100 ng/mL were
normalized to 0, 0.5, and 1 as input values to the FL gate (see Section 2.4). To compute
the output of a gate for a given set of input values, the first step was the fuzzification of
the input variables (see two examples in Figure 2-2G-H and described in text below).
Next, each rule was evaluated, and a degree of firing was calculated as the minimum of
the DOMs for the inputs and the rule weight [89, 93]. Finally, the outcomes of each rule
fired were resolved into a net output value by defuzzification (see Section 2.4). By way
of illustration, consider the two input scenarios in Figures 2-2G-H. In scenario 1 (Figure
2-2G), EGF=l (DOM to H=I), TNF=0 (DOM to L=I), and time=0.27 (DOM to L=0.4
and H=0.6). Rule 1 fired entirely (output IRS(S) was L) while rules 5 and 6 fired
partially because time had partial membership to L and H (antecedents for rules 6 and 5,
respectively); rules 2, 3, and 4 did not fire to a meaningful extent. Combining all these,
the aggregate gate output was -0.2, an intermediate value between the full L output from
rule 1 and the partial H output from rules 5 and 6. In contrast, scenario 2 (Figure 2-2H)
shows a condition (EGF=0O, TNF=1, time=0. 19) that led to full firing of rule 4 (though
this rule has a weight of 0.25), partial firing of rules 2 and 3, and negligible firing of rules
1, 5, and 6. The aggregate gate output in this case was -0.5.
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Figure 2-2 Fuzzy logic modeling process
As an example, local logic gate construction is illustrated for IRS(S) (IRS phosphorylation at serine 636).
(A) Logic-based models use incoming edges to contain activity level of input or regulatory network species(for IRS(S), the inputs were TNF, EGF, and time) with the logic gate at the node that performs the logic
operation to update output signal (IRS(S)). (B) A Boolean logic gate for IRS(S) could be represented in
terms of the logic statement "(TNF or EGF) and (NOT(time))", represented here in schematic form where
the top shape is an "OR-gate" the circle is a "NOT" operation, and the lower left shape is an "AND-gate").(C) The truth table for the logic in (B) states the output of IRS(S) (0 for off or 1 for on, in bold) based on
the input state. (D) To set up a FL gate, the first step is to assign membership functions (MFs) to the input
variables ("TNF", "EGF", and "time"). In this example, each input variable have two or three membership
functions ("L", "M", and "H" representing low, medium, and high states, respectively). An MF relates an
input value to that state's degree of membership (DOM). MFs for Fuzzy and Boolean (2 MFs)/discrete
multi-state (>2 MFs) logic forms are illustrated with the same state thresholds. (E) The simulations from
the Boolean logic gate shown in B-C is compared to experimental data and the Fuzzy logic gates specified
in F below (see Figure 2-5A for the experimental and simulation conditions). The BL gate is not able to
model intermediate state for smooth transitions, and simulations of the FL gate better fit the data as
compared to the BL gate. (F) To set up a FL gate, the MFs for the inputs and the constant values for the
outputs are defined. For simplicity, we use normalized input and output values. Next, logic rules are listed
as "if A (the antecedent), then B (the consequent)" using the input and output states as descriptors.
Weights between 0 and 1 are assigned to each rule (indicated in parentheses), which is helpful for rules that
should have minor influence (e.g. rule 4). The rules for IRS(S) are each graphically listed with the outline
of the membership functions specified for that rule's antecedent. Inputs not considered for an antecedent
are indicated by a light gray box. The consequent for each rule is indicated by a bar whose height is
proportional to the rule weight. (G-H) Two input scenarios are presented to illustrate FL gate computation
(horizontal gray arrows) and defuzzification (vertical gray arrow). The amount of color filled in (yellow
for inputs and blue for output) is representative of the DOM (for inputs) or degree of firing (DOF) given the
input values (for outputs). The input values are listed on the top and indicated graphically by the vertical
red lines. For example in scenario 1, rule 1 fires (full dark blue bar) because the antecedent (TNF is H) has
a high DOM (filled in yellow). The firing strength of the rule is the minimum of the antecedents; therefore,
rule 2 does not fire because while time has low DOM to L (-.4) and the DOM of time to H is near zero. To
defuzzify (resolve the output value given a set of firing rules), an average is computed from the output
values of each rule weighted according to both firing strength and rule weight. The bottom row in the
consequent column shows the aggregated outputs and the small red line is the defuzzified or final, value.
The scenario illustrations were adapted from the "rule viewer" in Matlab's Fuzzy Logic Toolbox.
2.2.3 Features of various logic gates
To model the experimental compendium data [58], eleven gates were constructed
using 2-4 input variables, 2-4 MFs per input, and 2-3 outputs per gate (see Figure 2-3).
Each is like a local model characterizing the regulation of the network species. Prior
knowledge in the form of a network diagram was used to choose the initial gates and their
inputs (Figure 2-4A). We aimed for numbers of inputs, rules, and MFs that were as few
and simple as possible while still fitting the data. The MFs and rules were manually fit to
the data, though future implementation of machine learning algorithms or automated
fitting should improve the speed and quality of the process (see below). By way of
illustration consider the JNK and MK2 pathways, which are activated by stress and
cytokine treatment and are thought to be co-regulated following EGF or TNF treatment
(Figure 2-4A, [36]). During the course of constructing gates for JNK and MK2, we
found that the data could be modeled without knowing whether or not EGF had been
added, suggesting that activation if JNK and MK2 in our data set was independent of
EGF-treatment (Figure 2-3B-C).
For some gates, tweaking of the MFs and rules was not sufficient to give a
reasonable fit and changes were required to the types and number of inputs. For
example, IRS-1 is the canonical adapter protein downstream of the insulin receptor,
though some of its many phosphorylation sites are also substrates of other receptor
kinases, including EGFR [94]. In modeling IRS-1 phosphorylation at two sites, tyrosine
896 (IRS(Y)) and serine 636 (IRS(S)), we found that both were regulated by TNF and
EGF but not by insulin (Figure 2-3F and 2-3J). The rules indicate that both TNF and
EGF treatment positively affect S636 phosphorylation while TNF inhibits EGF-induced
phosphorylation at Y896 (see Section 6.1.1).
During the formulation of the Akt gate, we included inhibitory crosstalk from
ERK to Akt because it has been observed in several experimental systems [95-97]. The
introduction of crosstalk greatly simplified the rule-base of the Akt gate, suggesting that
this crosstalk exists in HT-29 cells (Figure 2-31). The mechanistic basis for this crosstalk
is not understood in the literature, and our most effective model includes a short time
delay from ERK to the Akt gate input. Negative crosstalk from the ERK to Akt pathways
may be the mechanism by which TNF inhibits Akt phosphorylation upon insulin
treatment, as observed by Gaudet et al. [58].
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Figure 2-3 Fuzzy logic gate specifications
Each subfigure depicts the MFs and logic rules for the FL gates. The notation is identical to Figure 2-2,
except that rule weights are specified only when they are not 1 and input and output concentrations are
normalized (arbitrary units).
2.2.4 FL network modeling
An integrated model was constructed by joining together gates and four "inputs"
(TNF, EGF, insulin, and time). The signals produced by the FL gates are the model
outputs. Time delays were incorporated to model slow processes such as the induction of
autocrine transforming growth factor-a [TGF-a] following TNF stimulation [59]. A
maximization function was used to unite EGF and TGF-a (not shown) inputs because
they bind the same receptor and their contributions to the MEK and Akt FL gates were
similar (Figure 2-4B). To execute the model, a simulator stepped though small time
steps, updating the gates at each time step (see Section 2.4). The simulation results were
evaluated at twelve equal time intervals corresponding to experimental time points.
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Figure 2-4 Network diagrams
(A) The original network diagram is adapted from Janes et al. [59] and was used as a starting point to
construct the FL gates. "T", "E", "I", and "A" signals refer to signals associated with TNF, EGF, insulin,
and apoptotic signaling, respectively. Network species whose concentration was measured by Western blotin the data-compendium are notated with an orange square ("pS" for phospho-serine, "pY" for phospho-
tyrosine specific antibodies, "clv" for the cleaved form, and "pro" for the uncleaved form). Purple circles
mark data compendium proteins measured by kinase assay. (B) This diagram depicts the global FL model,
comprised of the 11 local FL gates with time delay and maximization functions. The network topology ofthe model differs from that of the original diagram.
We observed that our FL model recapitulated major features of the CSR dataset
across ten cytokine combinations (Figure 2-5A). For most signals, the differences
between the prediction and the data were minor with respect to signal amplitude and
timing. Common to all predicted signals was the absence of the activation lag at the
beginning of the time course. To model this lag would require an additional MF for
several gates, a feature we omitted for simplicity. It was also challenging to model
FKHR phosphorylation. Even though Akt is known to regulate FKHR [98], we could not
incorporate it as an input signal to the FKHR gate; instead, we modeled FKHR with
inputs of TNF, EGF, insulin, and time (Figure 2-3H). This suggests that in HT-29 cells,
FHKR is subject to more complex regulation than simply modification and activation by
Akt.
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Figure 2-5 The experimental data compendium and simulation of the global FL model
(A) The left heatmap portrays the averaged normalized data from the experimental compendium [58]. Ten
stimulation conditions with TNF, EGF, and insulin (top) are shown with the measurements at 0, 5, 15, 30,
60, 90,120, 240, 480, 720, 960, 1200, and 1440 minutes below. Measurement types (western blot or kinase
assay) are indicated in Figure 2-4A and are described in detail in Gaudet et al [58]. In the middle, the
heatmap shows the results of simulation using the global model under normalized treatment conditions,
corresponding with the data compendium shown on the right. Identical simulations of an equivalent
discrete logic model (DL, built by changing only the degree of fuzziness from the FL model and leaving the
rules and MF thresholds unchanged) are shown on the left (see Section 2.4). The cytokine treatment
concentrations are marked directly on the heatmap in ng/mL for the data and arbitrary units for the models.
See Figure 6-2 in the Appendices for an alternative depiction of the data and simulation results. (B-D)
Simulation and data time courses are plotted for three treatment conditions to highlight cases where the FL
model fit the data better than the DL model (B), where both models have similar performance (C), and both
models fail (D).
2.2.5 Comparison of fuzzy and discrete logic
To ascertain whether our FL model was superior to a BL model containing similar
gates and connectivity, the FL model was converted into a multi-state discrete model
(DL) by leaving the rules and rule weights intact and changing the degree of fuzziness in
the MFs to make them discrete (Figure 2-2D, Methods). Under these conditions, the
membership thresholds were the same in both the FL and DL models. The discretized
model was not a traditional Boolean model however, because the rules were overlapping,
making it possible for more than one to fire at the same time. Defuzzification was still
required to resolve the firing of multiple rules (see Figure 6-1 in the Appendices). We
chose this approach because we wanted to compare fuzzy and discrete models having the
same rule base. We anticipate that a more traditional Boolean model would, if anything,
be less adjustable and have poorer performance than the discrete model studied here (see
Figure 2-2E, Section 2.3, and Section 2.4).
To compare the FL and DL models to data quantitatively, we computed the fitness
as a normalized sum of squared differences (see below and Section 2.4). Over all
simulations, the FL model was a better fit to the data than the DL model (0.0312 and
0.0676, respectively). In evaluating fits to individual signals, we noticed patterns in the
types of data that FL and DL models were able to represent; three examples are shown in
Figures 2-5B-D. As expected, the DL model is not as capable as the FL model of
recapitulating intermediate activity levels (Figure 2-2B), and ERK activity in the DL
model alternated between low and high while the FL model more accurately reflects
graded ERK activities (Figure 2-5A). More striking breakdown between the DL model
and data was observed for Akt, IRS(S), and JNK (Figure 2-5A). For IRS(S) and JNK,
transient activation was not reproduced in 3 of 6 and 1 of 5 cytokine conditions, At early
times, the DL Akt gate was unable to replicate the intermediate activity levels. However,
because DL models generate step functions, they are well suited to sharp transient signals
(Figure 2-5C). In these cases, both the FL and DL models produced similar results. We
also observed cases where both models failed to fit the data, especially where there were
both early and late activation peaks (Figure 2-5D). This failure to fit data could be
remedied by adding more input states for time and altering the rules (Figure 6-2).
2.2.6 Towards a method for global rule fitting
In the work described above, logic rules and membership functions in the CSR FL
model were manually adjusted one gate at a time, but it would be preferable to perform
this adjustment automatically. We therefore developed an algorithm that optimizes the
weights of all possible rules for a gate by minimizing the sum of the squared differences
between the data and the model (see Section 2.4). Following optimization, logic rules
that are supported by the data should have weights near 1, while poorly-supported rules
should have weights near 0.
We tested the fitting algorithm with the MK2 gate. Using 2 MFs each for the two
inputs (TNF and time) and the output (MK2 activity), the gate has 23 = 8 possible explicit
rules. MK2 data from the 10 cytokine treatment conditions were used to optimize a
vector containing the 8 rule weights. Our initial fitting attempt failed because we were
using typical MFs for both inputs, including the time variable (not shown). This was
problematic because the time MFs were not parameterized to model the brief and rapid
increase in activation following cytokine treatment. While the difference was minor
when the data and the original model simulations are visually compared, the difference
was significant when quantified using the sum of squared differences. To account for the
lag, an additional MF for time was included to represent this immediate early response,
increasing the number of candidate rules to 12. Figure 2-6A shows simulated MK2
activity for the new MFs over time. The fitted gate reproduced the major features of the
data using 6 rules with weights near 1. The trained rules with weights near 1 matched our
manually determined rules (except for the rules describing the initial time lag, which was
not considered in the untrained gate, Figure 2-6B). To test FL gate regression with more
rules, we applied the algorithm to the same data using one additional membership
function (for medium activity levels) and compared it to an untrained model using the
same MFs. The trained rules were very similar to the untrained rules, and identified
applicable logic rules that we miss when writing the untrained gate (see Appendices,
Figure 6-4). The MK2 test case suggests that it is possible to optimize rule weights as a
means to fit logic rules without bias and is a first step towards a more rigorous approach
to logic-based modeling.
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Figure 2-6 Fitting MK2 rule weights
(A) A heatmap depicts the data, untrained model (Figure 2-3B), and trained model time courses for MK2.(B) The regressed rule weights are plotted for the 12 candidate rules. The rules are indicated in tabular
format; the first two rows describe the state of the inputs, TNF and time, and the last row is the output MK2
state. L and H represent low and high states, and E is the state describing the early response lag. Symbols
above the plot show whether the rules were present (/) or not applicable (Z) in the untrained model.
2.2.7 Biological predictions
As a second means to evaluate the FL model, we looked for new and potentially
testable biological insights (see also the Appendices, Section 6.1). Because each gate
effectively represents a local model of cell signaling, it is worth examining the
membership functions and the logic rules of gates themselves as their interconnectivity.
2.2.7.1 Mk2 and Erk co-regulation
The dataset includes measurements from three MAPK pathways: JNK, p38 (via
MK2), and ERK (with MEK). JNK and p38 respond to stress cues and, following
cytokine treatment, are jointly regulated by the upstream kinase MEKK5 [36]. Since
MK2 is a substrate of p38, it was not surprising to see a close correlation in the FL model
between JNK and MK2. MEK is the immediate upstream activator of ERK [36], but the
fit to ERK dynamics was much better if both MEK and MK2 were included as inputs to
the ERK gate; under these circumstances, only five simple rules were required to capture
rr u
iT
11 IM
ERK dynamics (Figure 2-3A, Figure 2-5A). Moreover, we judged MK2 to be superior as
an input to the ERK gate than TNF, EGF, and insulin because the rule-base was smaller.
In the final formulation, MK2 "OR" MEK positively influence ERK. The unexpected
involvement of MK2 in ERK regulation suggests either that MK2 regulates ERK in an
indirect or direct manner, or that MK2 is tightly correlated with an as-yet unidentified
ERK regulator. In previous PLSR modeling, we had observed a role for MK2 in cell
survival and the current data suggest that ERK may be an effector for the MK2 survival
function [43]. MK2 has previously been reported to regulate TNF and TGF-13 expression,
two ligands that regulate ERK by engaging cell-surface receptors [99-102], and it is
possible that the action of MK2 on ERK is autocrine-indirect; however the time-
independence of the interaction in FL model is suggestive of a more direct link.
2.2.7.2 EGF-stimulated inhibition of IKK
In general, TNF (but not EGF) is thought to be an upstream member of the
canonical pathway leading to IKK activation (Figure 2-4A, [103, 104]). However, there
is evidence that IKK is activated though the EGF receptor following EGF treatment in
other cell types (e.g. estrogen receptor negative breast cancer cells) [105]. In building the
FL gate for IKK activity, we were surprised to find that the gate's performance was
improved by adding a simple rule: "If EGF is H then IKK is L (weight 0.25)" (Figure 2-
3D). The necessity of this rule suggests that EGF is a weak, but not insignificant
inhibitor of TNF-mediated IKK activity.
We have previously reported that in HT-29 cells, TNF induces a complex
autocrine cascade in which TNF-induced TGF-a release acts through the EGF receptor to
stimulate release of interleukin-la [IL-lca] [59]. IL-laot was found to have an anti-
apoptotic effect via IKK -18 hr after TNF treatment. Because activated EGF receptors
are known to be down-regulated rapidly [106, 107], we hypothesize that in HT-29 cells,
EGF inhibits IKK activity following TNF stimulation by inducing EGF receptor down-
regulation. This in turn decreases the number of EGF receptors available to transduce
autocrine TGFa signaling, a necessity for IKK activation mediated by IL-la.
From these and similar examples described in Appendices (Section 6.1), we
conclude that potentially interesting biological insights can be drawn from the logic and
connectivity of FL gates including insights that were not apparent from simple inspection
of the data.
2.3 Discussion
In this chapter we describe the construction and evaluation of a fuzzy logic model
of mammalian signaling networks induced by TNF, EGF, and insulin. The logic gates
and their associated membership functions, which encode input-out relationships for
interactions among various species in the model, were generated based on study of
cellular responses to different cytokine treatments. The gates were then linked together
based on prior knowledge of network topology and DOFs fitted to data using either
induction or a more rigorous fitting process (based on minimizing the difference between
simulated and experimental trajectories). The resulting model was interpretable with
respect to interactions among species known, from the literature, to act in concert and it
generated dynamic trajectories for various species that were similar to those in actual
data. We can therefore conclude that efficient assembly of a FL network able to encode
complex experimental data is possible.
By building different versions of a FL gate, we were able to intuit potential
influences among data points in the data that had gone unnoticed during data-mining with
other analytic tools. For example, one biological hypothesis that arose from FL model
analysis is that MK2 and MEK are both co-regulators of ERK. This offers a novel
potential explanation for the previously published observation that MK2 activity has pro-
survival effects [43]. A second observation linking EGF treatment to IKK inhibition led
us to hypothesize that EGF-induced downregulation of the EGF receptor might interfere
with IKK activation by inhibiting TGF-a induced IL-o a autocrine signaling, which
requires the EGF receptor. Thus, the FL model yields predictions about the strength and
logic of both direct and autocrine-indirect processes. In the future, the process of
choosing the best FL model could be made more rigorous by automating the fit of rules
and membership function; this would make the process of hypothesis generation based on
model structure considerably more rigorous.
As a starting point to automated fitting of FL models to data, we show that FL
rules can be generated by regression to data. The potential for rule fitting opens a
plethora of possibilities for improving the capabilities of logic-based modeling and
exploring the effects of parameterization and imposed model constraints [108, 109].
Optimization algorithms such as genetic algorithms and Monte Carlo simulations could
be used fit membership functions and rule weight simultaneously. However, key to
developing an automated methodology for FL modeling would be the creation of a metric
to evaluate the performance of FL (and BL) models that balances the complexity of
model (and the associated degrees of freedom) with goodness of fit to data: incorporating
more gates and MFs usually improves the fit, but also increases significantly the number
of free parameters. For example, we observed that the capacity of multi-state discrete
logic gates to more effectively capture quantitative data features can be increased by
including a greater number of memberships (states) (see the Appendices, Figure 6-3).
Therefore, either fuzzification or inclusion of additional states can strengthen a DL
model. A solid metric of model quality would make it possible to compare FL and BL
models rigorously as well as evaluate models of the same processes that differ in
topology or MFs.
In conclusion, the current FL model of TNF/EGF/insulin-induced signaling in
HT-29 cells begins to explore the potential of FL methods to model cell signaling
networks. In the future, the introduction of automated model fitting, a graphical-user
interface tailored to biological applications, and better means to mine and incorporate
literature data should facilitate the application of FL modeling methods. Moreover, FL
models can be merged with differential equation models to form hybrid models with
particular utility in cases in which some process are well described, receptor-ligand
binding and immediate early signaling for example, but the biochemical details of
downstream processes such as induced gene transcription are less well specified. One
approach to such model fusion would be to reverse engineer part of a differential-
equation model to generate the look-up tables necessary for construction of various logic
gates. We are currently exploring these and other approaches to expanding the areas of
application of FL logic from industrial control to interpretation of complex biological
data.
2.4 Materials and Methods
2.4.1 Computational programming
The model was written and run using Matlab R2007a. Individual FL gates were
constructed and tested using the Matlab Fuzzy Logic Toolbox using the Sugeno inference
method. To parameterize the "gauss2mf"' membership function shape, a Python script
was used to coordinate the MF slope (.250 for FL and .0001 for BL models) with
intersections at a 0.5 DOM. Input and output values ranged from 0 to 1 for simplicity
and were empirically normalized. For example, each of the twelve time-steps in the data
compendium were equally spaced as inputs to the FL gates even though they were not
evenly spaced in real time. We used a default of two states (membership functions) for
each variable and the number was increased as needed (heuristically). We decreased the
number of free parameters by imposing a single degree of fuzziness on the model and
constants for output memberships. The global model was built and run in Simulink,
using its standard libraries for maximization functions, time, and time delays.
2.4.2 Model fitness
Model fitness was calculated by dividing the sum of the squared difference
between a model and the data by the number of data points. For the whole set of
simulations, there were 1430 data points.
2.4.3 Global logic gate regression
Rule weight optimization was achieved by using non-linear least squares
regression between the model and the dynamic data under the ten treatment conditions.
Because a gate's output is defuzzified by using a weighted average of the rules fired, sets
of firing rules can all have low weights without altering the final output. To highlight
firing rules in any circumstance, rule weights were normalized at each iteration of
optimization so that the weights of rules with the same antecedents sum to 1. Our
manually assembled gates were similar to the fitted gates, but necessarily contain
condensed and simpler rules sets. For example, we would write the rules "If TNF is L
and time is H then MK2 is L" and "If TNF is H and time is H then MK2 is L" in a
condensed form: "If time is H then MK2 is L". For rule fitting, we started by generating
full description versions of each possible rule. The optimization procedure was scripted
in Matlab R2007a and used the Matlab Optimization toolbox (lsqcurvefit).
3 Direct Lyapunov Exponent Analysis Enables Parametric
Study of Transient Signaling Governing Cell Behavior'
3.1 Introduction
Reaction models employing differential equations are frequently used as tools for
computational exploration of complex biomolecular networks, such as those involved in
signal transduction of extracellular stimuli governing cell fate. These models, generally
based on mass-action kinetics, incorporate network topology and quantitatively describe
the kinetics of interactions between network components [46, 50, 110-116]. Because
these mechanistic models are large and complicated, quantitative analysis is necessary to
extract understanding [114, 117]. A typical objective of model analysis is to
comprehensively characterize the response of the signaling network to changes in system
parameters. By altering network behavior, changes to protein levels or reaction rates may
lead to different cell fates following exogenous stimulation [118-121]. As an example,
activation of the small GTP-binding protein Ras can induce a variety of cell responses
including cell proliferation and differentiation, depending on the cell type and
extracellular conditions. Perturbations to the Ras-mediated regulatory network can
promote pathological cell behavior; mutations that affect Ras levels or binding or reaction
rates are often linked to cancer [122]. Numerous similar examples may be found
underlying cell behavioral dysregulation; thus, illuminating how changes in molecular
interactions alter signaling network behavior is key to understanding the molecular basis
of disease. Simulations can be used to inspect signaling behavior arising from network
3 This chapter is a postprint of the article 77. Aldridge, B.B., et al., Direct Lyapunov exponent analysis
enables parametric study of transient signalling governing cell behaviour. Syst Biol (Stevenage), 2006.
153(6): p. 425-432.
perturbations of potential interest - perhaps a genetic mutation or pharmacological
intervention [68, 114]. By simulating a mechanistic model, predictions can be made
about how specific changes to parameters such as stimulation or drug inhibition
conditions, initial concentrations, and reaction rates will affect signaling [47, 50, 123-
127]. To link different cell responses to complex signaling interactions, however, more
systematic, comprehensive analysis methods need to be applied.
Common systematic tools for studying the behavior of differential equation models
for signaling networks include parameter sensitivity analysis and steady-state analysis.
Determining sensitivity to rate constants and initial conditions (i.e., protein levels at the
initial time point) is useful for finding reactions and species that are particularly
important in the overall reaction scheme [76, 128, 129]. However, the local sensitivities
that may arise from intertwined multivariate interactions cannot be revealed by single-
parameter sensitivity analysis. A comprehensive analysis, where several parameters are
changed simultaneously, is often computationally impractical and the results intractable.
The analysis method presented in this work is based on direct Lyapunov exponents
(DLEs), which is a comprehensive local sensitivity analysis of model initial conditions.
The DLE approach can be interpreted in a manner that is analogous to steady-state
analysis of metabolic networks. Our analysis goal is to understand how the qualitative
network behavior (essentially, the biological fate) depends on the quantitative
combinations of network component parameters (essentially, the network state).
Steady-state analysis methods have been established in dynamical systems as
powerful methods for analyzing models of a variety of physicochemical processes,
including fluid flow and chemical reactions. These techniques, including fixed-point
bifurcation methods, have been successfully used to study several biological network
models. These methods delineate how changes in initial conditions and rate parameters
affect the biological outcomes associated with different equilibria. Good candidates for
this analysis are systems with multiple steady steady-states, where each phenotypic
behavior is associated with a particular steady-state. Examples include metabolic
networks, the cell cycle, and engineered gene networks [49, 110, 113, 130, 131]. In
contrast, many signal transduction networks affect cell fate through transient, pre-steady-
state signals. Here, we will refer to these systems as "transient response networks". In
transient response networks, rapidly-changing signals, or transients, induce changes in
other signals that propagate through the pathways [47, 58, 118, 126]. In these systems,
the time-evolution of transient signals, not steady-state signals, influences cell behavior.
For this reason, transient response systems may not be good candidates for steady-state
analysis. To understand these systems, we require methods that analyze transient signals,
such as DLE analysis described here.
The transient response system that we analyze in this work is a core sub-network of
the signal transduction cascade regulating the programmed cell death (apoptosis)-versus-
survival phenotypic decision. Apoptosis has in some previous work been modeled as a
bistable system where death and survival are distinct stable steady-states [132, 133].
However, this is not the only way, nor necessarily the most appropriate way, to cast a
problem that appears to involve a transient response network [43, 58]. In fact, models
focusing on the later stages of the apoptotic decision such as ours as well as one of the
alternative models developed by Eissing et al. do not exhibit bistablity [132, 133]. In
response to apoptotic stimuli, this network produces a transient response that is
dependent on the stimuli and the state of the cell. The transient signals will either lead to
apoptosis (where the network does not reset because the cell dies) or survival (where the
network resets).
Apoptosis is induced by extrinsic (receptor-dependent) and intrinsic (intracellular)
pathways. Common to both pathways is the activation of caspases, a family of proteases
that execute the cell death decision by cleaving protein targets. The caspases activate
each other to form a protease cascade and are themselves subject to regulation by many
other proteins [1, 17, 29]. Caspases are synthesized in an inactive state (pro-caspases or
zymogens) and become active when dimerized or cleaved by other caspases.
Intracellular or extracellular pro-death stimuli lead to dimerization and cleavage of
initiator caspases such as caspase-8. Once activated, these initiator caspases in turn
cleave and activate effector caspases such as caspase-3 (Figure 3-1). Activation of
initiator by effector caspases generates positive feedback that can amplify this cascade
[17, 18]. Prolonged activation of effector caspases leads to programmed cell death. A
critical inhibitor is X-linked inhibitor of apoptosis (XIAP), which negatively regulates the
enzymatic activity of caspase-3. Additionally, XIAP tags active caspase-3 for
ubiquitination. This modification promotes caspase-3 degradation and causes caspase-3
activity to be transient [27, 134].
Analogous to the application of steady-state analyses to signaling networks where
equilibria correspond to cell response, we describe direct finite-time Lyapunov exponent
(DLE) analysis as a method to study transient response signaling networks. We use
DLEs to analyze how transient signaling dynamics are affected as different parameters
change individually or simultaneously in multidimensional phase-space (the set of initial
chemical species concentrations). DLE analysis is not the first method to measure local
sensitivity analysis, but is distinguished from previously applied techniques because
DLEs are calculated as parameters change simultaneously, not individually [76]. DLEs
were originally used to find invariant manifolds in dynamical systems and fluid flows
[135-138]. Similarly, we use DLEs to find separatrices, or sensitive regions in phase-
space that separate signals giving rise to different responses. Separatrices are useful
because they quantitatively identify points at which continuous change in species
concentration lead to dramatic, discontinuous change in response. As an example of
current interest in molecular cell biology, we used DLEs to analyze a small, mechanistic
model of a transient response network describing caspase-3 activation in the network
described above. We were able to characterize initial conditions (concentrations of
protein species) leading to survival and apoptosis with the DLE-defined separatrix, but
not by examining steady-states. We thereby gained conceptual insight into the integrated
effects of multiple components in this network.
3.2 Methods
3.2.1 Caspase-3 activation model
A system of ordinary differential equations describing the activation of caspase-3
by caspase-8 was constructed using mass-action kinetics and the known topology of this
portion of the apoptosis regulatory network (Figure 3-1). We have made the following
central assumptions: [a] chemical species are present at spatially-uniform concentrations;
[b] caspase-6 is not involved in the feedback between active caspase-3 and caspase-8; [c]
ubiquitination can be represented by a single lumped reaction; and [d] caspase activation
is achieved after an inactive caspase interacts with an active caspase. The differential
equation describing the concentration of active caspase-3 tagged for ubiquitination (x9)
was removed from the model because it does not affect the network. Values for the rate
constants are listed in Table 3-1. The equations defining the model are as follows:
~1 = 
-kx 4xl + kdlx5
X2 = kd2x 5 - k3x 2x 3 + kd3x 6 + kd4X6
3 = -k 3x 2x 3 + kd3x 6
X4 = kd4x 6 - klx 4x 1 + kdlX 5 - k5x 7 4 + kd5 8 + kd2x 5
x 5 = -kd 2x 5 + klx 4x1 - kdlx 5
x6 = -kd 4X 6 + k3x 2x 3 - kd3x 6
x7 = -ksx 7x4 + kd5x 8 + kd6x 8
X8 = k 5x 7x 4 - kd5x 8 - kd6x 8
(2)
(3)
(4)
(5)
(6)
(7)
(8)
Figure 3-1 Schemstic of mathematical model for caspase-3 activation
Caspase-3 (casp-3) activity is regulated by caspase-8 (casp-8) and XIAP. Caspase-8 (an initiator caspase)
activates caspase-3 (an effector caspase) after forming a complex. Positive feedback is similarly
accomplished through activation of caspase-8 by caspase-3. XIAP inhibits active caspase-3 by tagging it
for ubiquitination and degradation. Here, a star indicates the active form of the caspases, a colon indicates
a complex, and 'ub' indicates ubiquitination tagging. Labels in blue and green correspond with species and
reaction numbers, respectively.
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Parameter Value Units
kl 2.67 x 10-9  cell*(s*molec) 1
kdl 1 X 10-2  S"1
kd2 8 x 10-3  S-1
k3  6.8 x 10"8 cell*(s*molec) -1
kd3 5 x 10-2  S- 1
kd4 1 x 103  s"I
ks 7 x 10-5  cell*(s*molec)'
kd5 1.67 x 10-5 s "1
kd6 1.67 x 10-4  s "1
Table 3-1 Parameter values and units
Parameter names include the reaction number and "d" for dissociation constants. All parameters except for
kd5 and kd6 were derived from a physico-chemical model fit to quantitative data from time courses of HT-29
human colon carcinoma cells treated with TNF [B. Schoeberl, S. Gaudet, D. Lauffenburger, and P. Sorger,
unpublished results]. kd5 was derived using parameters in [21]. The ubiquitination rate, kd6, was assumed
to correlate with an average delay of 100 minutes between ubiquitination tagging and degradation.
3.2.2 Direct finite-time Lyapunov exponent (DLE)
The DLE is a measure of local sensitivity to changes in initial conditions,
evaluated multidimensionally at a finite-time, as depicted for one dimension in Figure 3-
2. First, for a selected trajectory, the derivative of the current trajectory position with
respect to its initial location is calculated in all independent directions at each finite time
instant of interest. These directional derivatives are in turn assembled into a time-
dependent gradient matrix, whose entries are indicative of the rate at which neighboring
trajectories separate in the corresponding directions. The spectral norm (or largest
singular value) of the gradient matrix gives the instantaneous maximal rate of local
trajectory separation over all directions. The DLE associated with the selected trajectory
is then defined as the time-averaged logarithm of the above norm, measuring the maximal
rate of exponential separation between the underlying trajectory and nearby trajectories.
By definition, large DLE values reveal large local sensitivity in the flow with respect to
changes in initial conditions.
In numerical computations, we select a sufficiently dense grid of initial conditions
for which numerical differentiation gives meaningful results. We then launch trajectories
from each grid point and calculate the DLE value defined above for each trajectory. We
plot the resulting DLEs over the initial grid to identify locations of highly sensitive initial
conditions. Regions of phase-space exhibiting different qualitative behaviors are
necessarily separated by sensitive initial conditions, and hence their boundaries
(separatrices) will appear as local maximizers of the DLE field. The accuracy of
separatrix locations obtained in this fashion will increase as the initial grid size is refined.
By the continuous dependence of trajectories on initial conditions, separatrices are
captured by our procedure even if they do not exactly intersect the initial grid. This is
because separatrices have whole neighborhoods of increased sensitivity, which are
captured by a dense enough initial grid.
DLEs, apart from their application described here, are particularly useful in
finding repelling and attracting surfaces and have been used in fluid mechanics [137,
138] and rigid body dynamics [138]. In [135, 136], we proved that DLEs robustly
identify the locations of maximum stretching (divergence between nearby trajectories).
We use the maximum stretching among all dimensions to measure the rate of exponential
separation for a finite-time between two neighboring trajectories (Figure 3-2).
To quantify the degree of stretching at particular initial conditions, first we define
the separation (9) and approximate it by linearization (10).
;(t) = x(t,to,x o + 0o)-x(t,t o,Xo) = x(t,tox )o) +O(Io 2) (9)
ax(t)
;) N()--- o (10)
axo
Here x and ý are vectors describing species concentration and trajectory separation,
respectively. Next, we define stretching as the matrix (spectral) norm of the deformation
ax(t)gradient . Recalling
ax0
IIAI = max (AA)•2  (11)
for a square matrix A (where Amax (X) denotes the maximum eigenvalue ofX ), we obtain
x(t)2 = mx () (12)
We then define the finite-time maximal (over all directions) stretching rate experienced
along the trajectory x(t, to, xo) as
t -to  (t 1 t ax xo xo (13)
1Note that we can treat as a constant because the stretching rates are compared at
2(t - to)
a particular time t. Therefore, we can further simplify (13) to define the DLE by
factoring out this constant:
DLE(t, xo) = log A[max ) (14)
SAx(t1)-Ax(tO)I-.. s'maII rfl F
ax(t,)>>Ax(to)
•- large DLE
Figure 3-2 Large DLEs identify the location of maximum separation between trajectories, defining a
separatrix.
Direct finite-time Lyapunov exponents (DLEs) measure local sensitivity to initial conditions. Relative to
the time point used in the calculation of the exponent, small DLEs indicate little sensitivity (green). Large
exponents indicate high sensitivity near the initial conditions (purple).
3.2.3 DLE computation and visualization
Classical finite-time Lyapunov exponents are typically computed for
i = f(x,t) (15)
by numerically solving the linear system
8f
a= (x(t,to,xo),t) , (16)
obtained from differentiating (10) in time. By contrast, DLEs are computed directly from
(10), without the laborious solution of (16) along all trajectories. Specifically, we
compute finite-time Lyapunov exponents directly by differentiating final trajectory
positions with respect to their initial condition (hence the terminology "direct" Lyapunov
exponent).
To compute DLEs, a grid of initial conditions sampling phase-space was chosen,
and each set of initial conditions was integrated with respect to time using the ode 15s
solver in MATLAB 7.0 (The Mathworks, Natick, Massachusetts). The deformation
Ax(
ax(t)gradient was then obtained from a numerical differentiation of final trajectory
x0O
position with respect to their initial conditions. Next, the natural log of the maximum
eigenvalue of the strain tensor (aaX) ( ' () was computed to find the DLE, as
y8xo xo )
defined in (14), at each initial condition.
For a grid of approximately 1.6x10 6 points, the entire computation (including
trajectory integration) was completed in approximately 85 hours on a Linux workstation
with 2 GB of memory and dual 2.80 GHz Intel Xeon processors. The points on the grid
were linearly spaced along each direction. The MATLAB code performing the
computation is provided at http://cdp.mit.edu/. The resulting DLEs were visualized using
Spotfire DecisionSite (Spotfire, Somerville, Massachusetts).
3.3 Results
3.3.1 The cell phenotypic response of apoptotic death is governed by
transient signals in a caspase-mediated network
As a test case of a biologically-important transient response network, we explored
a mechanistic, differential equation-based model of caspase-3 activation depicted in
Figure 3-1. This network includes both pro-apoptotic elements (caspase-8 and caspase-
3) and a pro-survival factor (XIAP). While it has only eight distinct species (and
dimensions), our caspase-3 activation model is complex enough to be obscure without
analysis.
In the presence of active caspase-8, this network produces a transient response
that is dependent on the initial conditions (concentrations) of the eight network species
(Figures 3-3A-B). In cells, apoptosis is triggered by elevated and prolonged caspase-3
(or effector caspase) activation. Figure 3-3 shows simulated time courses (trajectories)
from our model, where apoptotic cells are categorized as exhibiting a relatively tall and
wide pulse of active caspase-3, while surviving cells are characterized by short and
narrow spikes of active caspase-3. As expected in a transient response system, we
observe that after loss of the transient signal, pro- and anti-apoptotic time courses
eventually reach the same type of steady-state (Figures 3-3C and 3-3D). A careful look
at the time-scale shows that it takes nearly a week for the pro-death signal to reach
equilibrium. In reality, such a cell would have died before the end of two days, and this
steady-state would never be reached. For simplification, this model does not include
protein turnover. We observed that the introduction of turnover into our model did not
significantly change its response (see the Appendices, Section 6.2).
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Figure 3-3 Time-course simulations show transient death and survival responses under two differentinitial conditions of XIAP.
(A) With little XIAP (2.9 x 103 molecules/cell) to inhibit activation of caspase-3, caspase-3 activation is
sustained and destines this cell for death. In these time courses, the initial conditions were 0 molecules/cellfor intermediate complexes and active caspase-3, 1 x 105 molecules/cell for active caspase-8, 1.34 x 105
molecules/cell for inactive caspase-8, and 2.67 x 105 molecules/cell for inactive caspase-3.
(B) With more XIAP (2.9 x10 4 molecules/cell), the pulse of caspase-3 activity is small and destines this cell
for survival.
(C,D) A longer time course shows that both apoptotic and non-apoptotic signals arrive at the same type of
fixed point. The simulation conditions are the same as in (A) and (B), respectively.
This preliminary inspection of the caspase-3 activation model demonstrates that
transient signals for pro- and anti-apoptotic conditions differ qualitatively. These two
types of trajectories separate from one another before reaching steady-state.
Furthermore, the behavior of the network is dependent on initial conditions. By
increasing the initial concentration of XIAP, the transient signal changes from a pro-
apoptotic to a pro-survival signal (Figure 3-3). We anticipate that there is a sensitive
initial condition of XIAP at which the behavior of the network changes, and that this
sensitive point will shift according to initial conditions of the active and inactive
caspases.
3.3.2 Large DLEs define a separatrix separating phase-space into pro- and
anti-apoptotic regions
As described in the Introduction and Methods sections, we employ direct
Lyapunov exponents (DLEs) to search our model phase-space for regions delineating
diverse behavior of transient network signals related to different cell phenotypic
responses (see Figure 3-2). Neighboring trajectories in these regions will veer away from
each other, thus exhibiting large DLEs that effectively define separatrices dividing the
phase-space into regions possessing different trajectory behaviors. Because DLEs are
calculated for the endpoint of the trajectories, they depend on the specific time-point at
which the trajectory separation is measured. This feature is a crucial aid in studying
transient response systems, for it insures that the analysis can be performed based on
transient signals.
To characterize the network's dependence on initial conditions in multiple
dimensions, we computed DLEs across an eight-dimensional grid spanning a wide range
of initial species concentrations. Totaling approximately 1.6 x 106 points, the grid points
are linearly spaced along each direction. These concentrations were chosen to encompass
protein expression across cell populations and under different signaling conditions in
Hct- 116, HeLa, and HT-29 carcinoma cell lines (102-105 molecules/cell for XIAP and
102-3.5x106 molecules/cell for the caspases [S. Gaudet and K. Leitermann, personal
communication]). Biochemical intermediates were sampled with coarser resolution
because they were not found to contribute to the network behavior (data not shown). To
find a separatrix, DLEs were calculated at six hours, by which time Hct-116, HT-29, and
HeLa cells would have responded to treatment with death-inducing ligands Tumor
Necrosis Factor (TNF) or TNF-related apoptosis-inducing ligand (TRAIL) [B. Aldridge,
unpublished observations]. To determine how narrow the time-window of effective
separatrix appearance might be, we additionally undertook DLE calculations across the
range between two and twelve hours, and found that the separatrix did not move
noticeably (data not shown).
Since it is problematic to simultaneously visualize the phase-space in eight-
dimensions, in Figure 3-4 we offer more accessible illustrations of the DLEs in three-
dimensional slices. Figure 3-4A illustrates the DLEs in the subspace containing XIAP,
caspase-8, and active caspase-8, whereas Figure 3-4B shows the DLEs in the subspace
containing XIAP, active caspase-8, and active caspase-3. Large DLEs (blue) define a
finite-time separatrix that identifies the points at which the balance between XIAP and
active caspase-8 shifts so that the overall response changes from pro-apoptotic to anti-
apoptotic signals. We expected the apoptosis regulatory network to have a separatrix
because the cell's response is either survival or death - it is not graded (from alive to sick
to dead). If a system were to exhibit a more graded response, the DLEs would have been
more uniform across phase-space and would not have yielded a discernible separatrix.
The location and shape of the separatrix provide a framework to generate
conceptual interpretation of network operation. The separatrix shifts towards higher
XIAP concentrations as the amount of active caspase-8 increases (Figure 3-4A). Cells
will die if above the separatrix, whereas below the separatrix there is enough XIAP to
overcome the conversion of inactive caspase-3 to active caspase-3 by active caspase-8.
The separatrix shape is invariant to inactive caspase-8, suggesting that the positive
feedback activating caspase-8 by caspase-3 has less influence than the regulation of
caspase-3 by active caspase-8 and XIAP. Since XIAP tags active caspase-3 for
degradation, more XIAP would be needed to rescue the cell from a death decision if there
was a higher initial concentration of active caspase-3 (Figure 3-4B). Figure 3-4C shows
perturbations to the separatrix as the ubiquitination rate constant is changed. As the rate
increases, so does the slope of the separatrix in the XIAP and active caspase-8 subspace.
The slower the ubiquitination rate, the longer the complex of active caspase-3 and XIAP
will exist, effectively lowering the concentration of free XIAP. We also observed that the
separatrix is not a simple plane - it curves at higher concentrations of active caspase-8
and shifts slope as the ubiquitination rate changes (Figure 3-4C).
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Figure 3-4 The six-hour DLE defines a separatrix separating phase-space into pro- and anti-
apoptotic decisions.
Phase-space subplots are shown on a linear scale with initial conditions of XIAP and the active caspases
ranging from 1 x 102 to 1 x 105, and 1 x 102 to 3.5 x 105 molecules/cell for the inactive caspases. All
concentrations refer to initial conditions. The subspaces plotted were chosen to closely match the protein
concentrations in untreated HT-29 cells [S. Gaudet and K. Leitermann, personal communication].
(A,B) Large DLEs of the caspase-3 activation network at six hours defines a separatrix. The blue curve is
the separatrix which divides the phase-space into regions where cells survive (to the right of the separatrix)
or die (to the left of the separatrix). (A) DLEs are shown in a subspace containing XIAP, active caspase-8,
and inactive caspase-8 with 2.6 x 105 molecules/cell of inactive caspase-3 and 1 x 102 molecules/cell of
active caspase-3 and the intermediate complexes. The gray curve highlights the separatrix, while the pro-
and anti-apoptotic regions are outlined in red and green, respectively. (B) DLEs are shown in the subspace
containing XIAP, active caspase-8, and active caspase-3 with 2.6 x 105 molecules/cell of inactive caspase-3
and inactive caspase-8, and 1 x 102 molecules/cell of the intermediate complexes. The stars indicate
reference points (individual cells with different protein levels). The red and purple cells are pro-apoptotic
while the green and orange cells are anti-apoptotic.
(C) The separatrix shape is sensitive to rate constants. As the rate of ubiquitination is decreased (kd6
increased), the slope of the separatrix increases. The DLEs are shown in the subspace containing XIAP and
active caspase-8, with 2.6 x 105 molecules/cell of inactive caspase-3 and inactive caspase-8, and 1 x 102
molecules/cell of the intermediate complexes and active caspase-3. From low to high, the rate constant kd6
has values 3.33 x 10-5, 1.67 x 10-4, and 8.3 x 10-4 s-1.
In addition to using the separatrix as a tool to help us interpret the decision-
making mechanisms of the network, the separatrix quantitatively identifies the critical
ratios of initial conditions around which the cell response changes. By comparing the
location of different cells in phase-space to each other and the separatrix, we can evaluate
how differences in species concentrations affect differential cell behavior. It is
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informative to note that the location of a cell in phase- or concentration-space affects how
the network reacts to signals. For example, consider two cells in the pro-apoptotic
section of phase-space that have different XIAP concentrations (as indicated in Figure 3-
4B). The purple and red starred cells are close to and far from the separatrix,
respectively. The red starred cell requires an eight-fold increase in XIAP concentration
to cross the separatrix (to reach the green star) while the purple starred cell needs a
modest two-fold increase. Alternatively, the red starred cell could move to the separatrix
by increasing its XIAP concentration six-fold while decreasing its active caspase-8
concentration by one half (orange star). If the XIAP concentration is increased four-fold
in both cells, the cells will behave differently and only the purple starred cell will cross
the separatrix to survive. This simple example illustrates that we need to know the cell's
state (key species concentrations) before predicting response. The DLE-defined
separatrix helps us understand how cells in different states can have disparate responses
to the same stimulation or perturbation.
3.3.3 A steady-state analysis cannot distinguish pro- and anti-apoptotic
responses across phase-space
Direct analysis of the set of nonlinear algebraic equations representing our model
at steady-state showed that the system has four types of equilibria (i.e., four invariant
manifolds filled with fixed points, in contrast to four fixed points) with only one type
being stable (Figure 3-5A, Appendices Section 6.2). These stable fixed points can have
non-zero valued concentrations of caspase-8 and XIAP. However, the concentration of
caspase-3 must be zero because any inactive caspase-3 would be activated by caspase-8
and subsequently degraded by XIAP before a steady-state is reached. The phase-space
locations of these stable fixed points are dependent on initial conditions.
To investigate whether these stable steady-states segregate into pro- and anti-
apoptotic clusters, we plotted the steady-state locations from small subsets of trajectories.
Figures 3-5B-D show active and inactive caspase-8 equilibrium concentrations from
different small sets of trajectories. Within each set, the initial conditions of inactive
caspase-8 were constant and most steady-states cluster into death or survival locales. For
example, cells that survive stimulation with a death stimulus generally have low active
and high inactive caspase-8 concentrations because caspase-3 was not activated enough
to convert most of the inactive caspase-8 to the active form. This suggests that within a
small set of initial conditions, a separatrix can be identified by plotting stable fixed
points.
However, when we plotted trajectories from a broader range of initial
concentrations of caspase-8, the ability to distinguish cell fate based on steady-state
locations is lost (Figure 3-5E). In contrast, DLEs can separate the two fates without
considering steady-state values. We have seen in Figure 3-4 that large DLEs can define a
separatrix over a broad set of initial conditions. For the small sets described above,
equilibria between the clusters have large DLEs and separate the groups representing
surviving and dying cells (Figure 3-5B-D). We conclude that DLEs are versatile and can
be applied regardless of whether or not steady-states cluster by behavior (Figure 3-5F).
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Figure 3-5 Stability and steady-state analyses of the caspase-3 activation network model.(A) Stability analysis shows one stable (purple) and three unstable (green) types of fixed points(Appendices Section 6.2). Every type of fixed point requires concentrations of zero for the intermediate
complexes. For each of the four fixed point types, there are two or three species that can be nonzero. The
green (unstable) and purple (stable) circles indicate which species can be nonzero for each type of fixed
point.
(B-E) The steady-state locations in the caspase-3 activation network are not globally clustered. The fixed
points are plotted in the subspace containing active and inactive caspase-8, with increasing initial
concentrations of inactive caspase-8: (B) 8.8 x 104, (C) 18 x 105, and (D) 3.5 x 105 molecules/cell. Other
initial conditions were 2.6 x 105 molecules/cell of inactive caspase-3, I x 102 molecules/cell of active
caspase-3 and the intermediate complexes, and I x 102 - 1 x 10s molecules/cell for active caspase-8 andXIAP. For each initial concentration of inactive caspase-8 (B-D), the steady-states are moderately
clustered and are segregated by large DLEs (blue). However, the fixed points from different inactive
caspase-8 initial conditions do not cluster when plotted together (E).(F) A schematic compares the use of steady-state and DLE analysis methods. In systems where steady-
states localize to different regions of phase-space (left), steady-state analysis methods may be used to
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characterize the phenotypic behavior of the network. DLE analysis can distinguish between behaviors in
networks regardless of fixed point clustering.
3.4 Discussion
Our goal here is to develop an analysis methodology for differential equation
models aimed at understanding how transient signals influence phenotypic responses -
i.e., to develop signal-response relationships for most transient response networks in
higher cells. Many signal transduction networks are transient response networks,
meaning that they affect phenotypic cell responses before a steady-state is reached.
Therefore, the steady-state and bifurcation analysis methods traditionally used to study
differential equation-based models do not find straightforward application to transient
response networks. To successfully analyze complex networks, we required that our
methodology be applicable to transient signals across multiple dimensions.
Towards this challenging goal, we have described the use of direct finite-time
Lyapunov exponents to study differential equation models of transient response
networks. DLEs measure the separation between initially nearby trajectories in phase-
space. We have used DLEs to identify sensitive regions of phase-space where small
changes in the initial concentrations of network species alter cell fate (Figure 3-2). The
separation can be calculated at any specific point in time, permitting prior biological
knowledge concerning the most relevant experimental measurements to be leveraged.
DLEs enable an exhaustive, multidimensional analysis of transient signals because they
measure trajectory separation with respect to each dimension across the entire phase-
space. As a result, DLEs are capable of identifying both important network interactions
and in what context they affect signaling (i.e., at what time or under which sets of initial
conditions). By searching phase-space for sensitive initial conditions (those with large
DLEs), we can identify surfaces (separatrices) that separate different classes of signals.
A separatrix specifies critical combinations of species concentrations around which
signaling changes qualitatively. Because we can visualize the separatrix in different
regions of phase-space, DLE analysis enables us to quantitatively interpret complex
signaling interactions.
In applying DLE analysis to other biological signaling networks, a few
considerations must be explored. DLE analysis is a numerical method which is flexible
in the grid resolution and finite-times chosen for evaluation. While this flexibility is an
asset for studying biological systems which have different time scales and varying
parameter sensitivities, crude choices of time and phase-space grid may not capture all
separatrices of interest. Because of the continuous dependence of trajectories on initial
conditions, however, the DLE computation is a convergent procedure: refined grids and
longer integration times are guaranteed to capture all separatrices. A second
consideration is the relative strength of rates at which trajectories diverge at different
locations in phase-space. Large rates of divergence will dominate the calculations,
possibly obscuring smaller but biologically important trajectory separations. Therefore, it
is important to select visualization methods that identify local features of the DLE field
efficiently, thereby ensuring that all key behaviors are illuminated.
As a particular example of current biological interest, we applied DLE analysis to
a model of caspase-3 activation involving caspase-8 and XIAP. The model responds to a
pro-death stimulus with a transient signal leading to either death or survival. This
network is an example of a transient response network: it has only one type of stable
steady-state and the survival-vs-death decision is made before this steady-state is reached.
This notion of transient response signaling in apoptosis differs from some previously
published models, which have cast this phenomenon as a multiple steady-state problem
and analyzed it accordingly [132, 133]. Although some insights concerning model
parameter effects were gained in those contributions, recent experimental studies focused
on dynamic and integrative measurement have demonstrated that the key signals
governing the phenotypic outcome of cell death-vs-survival are transient [43, 58]. Before
stimulation, this network rests at a basal steady-state. Upon stimulation, a transient signal
is produced during which the life-vs-death outcome is decided. Cells that survive return
to the basal state. Thus, all key physiological signaling occurs during the transient phase.
While our model describes only a subset of the complex network regulating
caspase-3, the model has eight species and is too complex to comprehensively
characterize by inspection or parameter sensitivity analysis. Because DLE analysis is
time-dependent and multivariate, we were able to gain specific insights about the
regulation of caspase-3 that most likely would have been overlooked by inspection,
single-parameter sensitivity analysis, or steady-state analysis (Figure 3-5F). Large DLEs
defined a separatrix, from which we were able to gain quantitative, multivariate insight
into the death-vs-survival decision. The separatrix classified two types of transient
signals and defined the conditions leading to apoptosis and survival (Figure 3-4). We
observed that the shape of the separatrix is not a simple plane and its shape and slope are
dependent on rate constants. This suggests that in cases where reactions rates are hard to
measure, the constant could be fit by comparing an experimentally identified separatrix
with computationally predicted separatrices.
We envision DLE analysis as a tool for addressing challenging practical problems
such as understanding the role of cell population heterogeneity in disease diagnosis and
treatment. Others have described how population averages differ from the behavior of
single cells by using population heterogeneity [125, 132]. DLE analysis can be used to
investigate a key tangential question: How does population heterogeneity of protein
expression correlate with different single-cell behaviors in a population of cells? To
study the effects of noise and variability in protein expression within a population of
cells, we can compare the concentration distributions of key proteins with separatrices.
Intersections between these distributions and separatrices should correlate with
heterogeneous responses. For example, when cells are treated with a saturating
concentration of TNF, a death-inducing ligand, only approximately 60% of a population
of HT-29 cells die [58]. While not understood in quantitative terms, the TNF receptor is
known to activate both pro-survival and pro-apoptotic pathways. The pre-Death Inducing
Signaling Complex (pre-DISC) activates the nuclear factor-KB (NF-KB) pathway (a pro-
survival pathway which upregulates XIAP) before activating caspase-8 and the
mitochondrial pathway. Activation of the mitochondrial pathway causes the
mitochondria to release Smac, a pro-apoptotic protein which inhibits XIAP. It is likely
that within a cell population, basal protein expression variation can affect network
behavior by changing the concentrations of key regulatory proteins such as XIAP. In the
future, the phase-space locations of HT-29 cells could be determined experimentally by
measuring the distribution of caspase-3, caspase-8, and XIAP expression levels. By
evaluating their proximities to the separatrix, we could determine if the distribution of
protein expression levels in a cell population can cause a heterogeneous response to TNF
treatment. Eventually, we anticipate that DLE analysis can help us understand the
transformation of a cell from a healthy to diseased state, and identify what changes in
species concentrations are required to move the diseased cell across the separatrix to a
healthier condition.
4 Quantitative Analysis of the Mitochondrial-pathway
Requirement for Receptor-mediated Apoptosis
4.1 Introduction
It is generally thought that cells undergoing apoptosis can be classified into two cell
types based on their dependency on the mitochondrial pathway: Type I cells are
mitochondria-independent and Type II are mitochondria-dependent, Figure 4-1. The
initial classification found that cell death occurred in both cell types at similar times after
treatment with Fas but the activation of initiator and effector caspase was slower in Type
II cells [16]. The control point that distinguishes the use of the two pathways is
understood to be at the level of differential DISC formation triggering initiator caspase
activation [139]. Type II cells are most commonly identified by protection from death-
ligand induced apoptosis by Bcl2 overexpression or similar impairment of MOMP.
Several additional descriptors to classify cells have been reported and include strong
activation of death receptors and caspase-8 in Type I cells, differential sensitivity to
different Fas ligand forms, and dependency on F-actin in Type I cells for receptor
internalization [139, 140]. Recently, a panel of 58 tumor cell lines from the National
Cancer Institute's libraries were classified, and Type I and Type II cells were found to
have different gene expression patterns, though the molecular mechanism driving these
changes have yet to be established [141].
While HeLa cells have been described as Type II because they are resistant to
receptor-induced apoptosis when MOMP is impaired, we have observed partial caspase
activation in Bcl2 overexpressing HeLa cells that were partially depleted of XIAP [142].
Because XIAP depletion diminished the protection by Bcl2 overexpression to TRAIL-
induced apoptosis, making them intermediate between Type I and Type II cells, we
hypothesized that control of Type I vs. Type II may also occur at the level of effector
caspases.
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Figure 4-1 Pathways used in in Type I and Type II cells
Type I and Type II cells are distinguished by their dependence on the mitochondrial pathway to undergo
apoptosis. Type II cells require the mitochondrial pathways and Bcl2 expression protects Type II cellsfrom apoptosis. Type I cells do not require the mitochondrial pathway and activation of caspase-3 by
caspase-8 is sufficient to trigger cell death. Proteins blocked by Bcl2 overexpression are faded.
To investigate the basis for Type I or Type II behaviors, we use a systems
approach that combines kinetic modeling and detailed dynamic analysis with quantitative
data of the concentrations and kinetics of proteins involved in this cell-decision network.
We perturb the ratios of caspase-3 to XIAP (and ubiquitin-ligase-mutant XIAP) and
observe in single cells the kinetics of caspase-3 activity with flow cytometry and FRET-
based reporters in live-cell microscopy. We combine our single-cell data with a
Lyapunov exponent-based analysis of a physicochemical model of receptor-mediated
apoptosis. We show that Type II cells behave as Type I cells following depletion of
XIAP in Hctl 16 colon carcinoma cells. This supports our hypothesis that the control of
Type I/Type II pathway usage can be controlled at the level of effector caspase
activation. We use our data and computational modeling to define network conditions
that yield Type I, Type II, and Type I/II intermediate behaviors. This characterization
may provide a framework to identify characteristics of tumor types that will be
susceptible to lAP-targeted cancer therapeutics.
4.2 Results
4.2.1 Modeling Type I vs. Type II responses
To explore the factors that differentiate Type I from Type II cells, a mathematical
model of the signaling network that regulates caspase activity was analyzed (Figure 4-1).
The differential equation model was built using mass-action kinetics to describe
elementary reactions between network species (proteins, complexes, etc.) as described in
the Section 4.4.1 and [77]. Our model was adapted from a 58-species model developed to
describe apoptotic signaling events in HeLa human carcinoma cells following treatment
with TRAIL and CHX [142, 143]. Because our experimental studies are based on
Hctl 16, not HeLa cells, and focus on effector caspase activation, we updated several
parameters in the model. We replaced the kinetic rate parameters used to describe
caspase-3 and XIAP interactions to the rates used in our smaller model of caspase-3
activation (Chapter 3). These association and dissociation rates were determined
experimentally [21], and the ubiquitination rate was estimated (as discussed in Chapter
3). Futhermore, in the original model, active caspase-3 is actively degraded by XIAP-
mediated ubiquitination. However, it has been recently reported that active caspase-3 is
also targeted for degradation by other mechanisms [144]. In preliminary studies, we
observed that about 80% of cleaved caspase-3 degradation is XIAP- or proteasome-
independent in Hctl 16 cells (results not shown). We therefore increased the constitutive
degradation rate of active caspase-3 by 5-fold. To match protein concentration estimates
in Hctl 16 cells, the initial concentration for XIAP was reduced by 70% to 30,000
molecules per cell and that of caspase-3 was increased by 10-fold to 100,000 molecules
per cell [K. Leitermann, S. Gaudet, and P. Sorger, unpublished observation].
With the model adapted for Hctl 16 cells, we next tested whether it could be used
to exhibit both Type I and Type II behaviors. Simulation of the baseline model shows that
PARP was cleaved with the characteristic all-or-nothing response (Figure 4-2). When the
initial concentration of Bcl2 was increased 10-fold to simulate the experimental case of
Bcl-2 overexpression, PARP cleavage was severely diminished. Because an increase in
Bcl-2 initial condition protected PARP from being cleaved, the baseline model, like
Hct 116 cells, behaves in a Type II manner [141]. To test whether a Type I behavior
could be observed with the same model, we increased the rates regulating DISC
formation and activation of caspase-8 by the DISC by 10-fold (Figure 4-2 and Section
4.4.1, [145]). When the Hctl 16 model was simulated with both baseline and 10x Bcl2
initial concentrations, PARP was rapidly cleaved and the model therefore behaved as a
classical Type I network, in which increased DISC and initiator caspase activity can
bypass the requirement for the mitochondrial pathway.
Type II Type I
baseline faster DISC XIAP KO
baseline
OA
u 0.2
1 -
0 ois
V 0.6B12 OE 2
u 0.2
0
0 6 12 0 6 12 0 6 12
time, h time, h time, h
Figure 4-2 Predicted Type I and Type II behavior
Simulations of PARP cleavage are plotted under different network conditions for 50 ng/mL of TRAIL
stimulation. The baseline case models Hct 116 cells. Bcl2 over expression (modeled as a 10-fold increase
in Bcl2 initial concentration) is protective against PARP cleavage for the Hctl 16 model, predicting Type II
behavior in agreement with experimental data [141]. The model behaves as a Type I cell when
parameterized for faster DISC activation (10-fold increases in rates of DISC assembly and activation of
caspase-8 at the DISC, see Methods) or with XIAP KO (modeled with XIAP's initial concentration set to
zero).
4.2.2 XIAP depletion converts Type II cells into Type I cells
Based on the observation that an intermediate Type I/Type II behavior was seen
in XIAP knockdown HeLa cells, we next investigated whether XIAP plays a role in
determining mitochondrial dependency in apoptosis. The significance of XIAP and its
ubiquitinase activity in the apoptotic decision has been debated in the literature [146-
150]. On one hand, XIAP has been shown to inhibit and ubiquitinate caspase-3 and
caspase-9 in vitro and inhibition of XIAP by Smac mimetic small molecules has been
shown to potentiate TRAIL-induced apoptosis [26, 150, 151]. On the other hand, XIAP
knockout mice survive to adulthood and exhibit no disease, arguing that it has little
influence on the cell death decision [146]. We have previously observed that XIAP is
critical in the death decision when the mitochondrial pathway is blocked; we observed a
"partial death" phenotype in Bcl-2 overexpressing HeLa cells (Type II) that were
partially depleted of XIAP by RNAi. These cells do not exhibit the characteristic snap-
action caspase-activation, and some but not all of the PARP is cleaved in each cell [142].
Under Bcl-2 overexpression, caspase-3 is inhibited by XIAP and release of Smac from
the mitochondria in blocked, eliminating an inhibitory mechanism of XIAP [151, 152].
From this, we believe that the conflict in the literature whether or not XIAP is key to cell
death decision is likely due to the fact that the role of XIAP is context dependent.
Together, our RNAi experiments and model analysis suggested that sensitivity to XIAP is
dependent on both MOMP and XIAP [77, 142].
This is important because it implies that control of Type I vs. Type II may not
occur only at the level of DISC formation and caspase-8 activation as described
classically, but also at the level of effector caspase regulation. Because high
concentrations of XIAP can hold the activity of caspase-3 in-check prior to MOMP, we
predicted that XIAP depletion in some Type II cells should reverse the protection against
apoptosis under Bcl-2 overexpression (similar to the observed behavior of Hctl 16 cells
treated with Smac mimics and NSAIDs [152]). Simulations support this notion and
demonstrate that depletion of XIAP converts the model from a Type II to a Type I
behavior (Figure 4-2).
Another point of controversy surrounding the role of XIAP in apoptosis
regulation is whether its ubiquitin ligase function is important. To establish whether the
apoptotic response in Type II cells was dependent on ubiquitination, we assayed caspase-
3 cleavage and PARP cleave in Hctl 16 cells using flow cytometry at 2, 4, and 6 hours
after treatment with CHX, TRAIL, and with and without the proteasome inhibitor
MG132 (Figure 4-3A, Section 4.4). We used caspase-3 cleavage as a proxy for initiator
caspase activity because caspase-3 is a substrate of the initiator caspase. Similarly, we
used cleaved PARP as a proxy for effector caspase activation. The apoptotic state cells
can be evaluated by plotting the two-color FACS data. In the lower left quadrant (little
cleaved caspase-3 or PARP), cells were alive and did not have active caspases (Figure 4-
3F). They progressed towards the death state of fully activated initiator and effector
caspases (upper right quadrant in Figure 4-3F) through a transition state characterized by
active initiator and inactive effector caspase activity (cells in the lower right quadrants in
Figure 4-3F). In Hctl 16 cells, apoptosis progressed through the transition state as
caspase-8 was activated between 2 and 4 hours following CHX+TRAIL treatment, and
caspase-3 was activated in most cells by 4 hours. When co-treated with MG132, the
dynamics of caspase-8 activation were unchanged but caspase-3 activation occurred
much more rapidly (it is complete after 4 hours) and the transition state was not observed.
This implied that caspase-3 activation was contemporaneous with caspase-8 activation.
Hct 116 Bax KO cells had similar patterns of caspase-8 activation to the parental line, but
caspase-3 was inactive and the cells arrested in the transition state (Figure 4-3C).
Confirming that Hctl 16s are Type II, blocking MOMP with Bax KO or Bcl2 OE
protected the cells from receptor-induced apoptosis (Figure 4-3B). Protection against
apoptosis was lost in Bax KO cells in the presence of MG132, and caspase-3 activation
followed caspase-8 activity quickly (no transition state was observed, Figure 4-3B-C).
Significantly, these data suggest that Bcl2 protection against apoptosis in Type II cells is
proteasome-dependent.
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Figure 4-3 Single cell responses to CHX, TRAIL, and MG132
Hctl 16 derived cells were treated with 2.5 pg/mL of CHX + 50 ng/mL of TRAIL and 10 pM MG 132, a
proteasome inhibitor. A two-color FACs assay for cleaved caspase-3 and cleaved PARP measure initiator
and effector caspase activity, respectively, in Hct 116 (A) parental cells, (B) Bcl2 OE cells, (C) Bax KO
cells, (D) XIAP KO cells, and (E) Bcl2 OE XIAP KO cells. (F) A schematic shows the two-colored FACS
assay for initiator caspase activity (cc3) and effector caspase activity (cPARP). Bcl2 OE cells are from a
pool and not from a single clone of 10x OE (as is shown in the rest of this chapter). Impairing MOMP
through Bcl2 OE or Bax KO blocks death with TRAIL but not in the presence of MG 132. Therefore, the
Type II behavior is lost with MG-132 treatment. XIAP KO cells are not protected by Bcl2 OE and the
response to CHX+TRAIL treatment is similar to MG132 treatment in XIAP +/+ cells.
Because MG132 treatment accelerated effector but not initiator caspase
activation, we speculated that MG 132 blocked the ability of XIAP to tag active caspase-3
for ubiquitination and subsequent degradation; XIAP is specific for effector caspases and
not initiator caspases. To experimentally validate the influence our hypothesis on Type I
vs Type II behavior, we produced Hctl 16 parental and XIAP KO cell lines that stably
overexpress Bcl2 (Section 4.4.2). At a 10-fold overexpression level of Bcl2, MOMP was
fully blocked (data not shown). When treated with CHX and TRAIL, the Bcl2 OE
parental cells activated caspase-8 but PARP was not cleaved (Figure 4-3B). MG132
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treatment in XIAP KO cells had mild effects, introducing a small population of cells that
appeared to die with relatively low caspase-8 activity (Figure 4-3 bottom). Finally, the
Bcl2 OE XIAP KO cells were unable to survive the CHX/TRAIL treatment and exhibited
a Type I behavior, again showing the role of XIAP protein on the determination of Type
I/II behavior (Figure 4-3E, [16]).
While flow cytometry analysis provides a picture of the state of many cells at
different time points, it is difficult to derive precise information about signaling dynamics
from these data. To further characterize the effects of MG132 and XIAP knockout on the
dynamics of caspase-3 activity, we used a FRET-based reporter that measures effector
caspase activity in live cells (described in Section 4.4.5). Briefly, with this reporter,
higher FRET ratios indicate greater accumulation of cleaved product from effector
caspase activity. The FRET ratios of individual cells were tracked and plotted in Figure
4-4. We observed that effector caspases in Bcl2 OE XIAP KO cells were activated
suddenly with a very steep increase in FRET ratio -75 minutes after treatment with either
CHX+TRAIL or CHX+TRAIL+MG132. By contrast, Hctl 16 Bcl2 OE cells treated with
CHX+TRAIL exhibited a slow and steady rate of effector caspase activity. Notably, the
rate of caspase-3 activation was variable, which may be dependent on XIAP
concentration; we speculate that Bcl2 OE cells with higher rates of caspase-3 activation
have less XIAP than neighboring cells displaying less caspase-3 activity. Finally, the
rapid increase in effector caspase activity was restored in Bcl2 OE cells with MG 132
treatment, confirming the results obtained by flow cytometry showing that proteasome
activity is required for Type II behavior.
To ensure that the switch from Type II to Type I behavior in XIAP KO cells was
not an effect of compensation or adaptation to the knockout, we performed a
complementation assay by transient transfection of mCherry-XIAP into 10x Bcl2 OE
parental and XIAP KO Hctl 16 cells (Section 4.4.4). In Figure 4-5, the mCherry positive
cells (in green) survived in the transition (active initiator caspase, inactive effector
caspase) state while the mCherry negative cells died, confirming that change in XIAP
concentration was solely responsible for the switch between Type I and Type II
behaviors. In a parallel assay, we transfected the same cells with a ubiquitin ligase
defective form of XIAP (mCherry-XIAPH467A). Because more ubiquitin ligase-
deficient XIAP was needed to rescue the Bcl2 OE phenotype in XIAP KO cells (as
compared to mCherry-XIAP, Figure 4-5, Section 4.4), we conclude that the mechanism
of inhibition of caspase-3 by XIAP requires both competitive inhibition of substrate
binding and ubiquitination.
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Figure 4-4 Dynamics of caspsae-3 activity
Live-cell microscopy with a FRET-based reporter for effector caspase activity was used to measure the
dynamics of caspase-3 activity in response to NT (no treatment) or 2.5 ljg/mL of CHX + 50 ng/mL of
TRAIL with or without 10 pM MG132. The FRET ratio increases as caspase-3 is activated (Section 4.4).
The Bcl2 OE cells are derived from a pool of selected transfectants and not a single clone and therefore the
level of everexpression between cells is variable. Two cells are shown for each cell type and condition,
except for Bcl2 OE cells treated with CHX+TRAIL for which three cells are shown. These cells lost the
snap-action activation of caspase-3 compared to the parental line, but the rate of caspase-3 activation was
variable, probably due to variation in protein concentrations of XIAP. Hctl 16 cells are highly motile and
each curve is the time course of a tracked representative cell.
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Figure 4-5 XIAP KO converts Type II Hctll6 cells into Type I cells
The single cell response to CHX+TRAIL treatment is plotted for Bcl2 OE Hctl 16 and Bcl2 OE XIAP
Hct 116 cells. The cells were transiently transfected with mCherry-tagged XIAP or XIAP H467A (a RING-
domain mutation that abolishes the E3 ubiquitintin ligase activity of XIAP). mCherry, initiator caspase
activity (cc3), and effector caspase activity (cPARP) were measured by FACs and are plotted as cc3 vs
cPARP (top) and mCherry vs cPARP (bottom). Cells expressing mCherry are were gates as shown in the
bottom figures and labeled green in the top figures. XIAP KO cells are not protected by Bcl2 OE and
therefore behave as Type I cells. Complementation with mCherry-XIAP restores the protection by Bcl2
OE (green). More XIAP H467A is required to restore Bcl2 OE protection than XIAP.
4.2.3 Continuum of Type I and Type II doses responses to TRAIL
Having identified two ways in which cells can become mitochondria independent
or Type I, we next investigated whether the cell types could be differentiated based on
their dose responses. Figure 4-6A depicts our initial prediction that all cells should
behave similarly when treated with low concentrations of TRAIL, but the responses will
gradually diverge at medium and high concentrations of TRAIL with MOMP-impaired
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(such as Bcl2 OE) Type II cells dying only when stimulated with very high
concentrations of TRAIL. The Hctll6 model's dose response to 0, .0032, .016, .08, 0.4,
2, 10, 50, and 250 ng/mL of TRAIL at 8h shows no PARP cleavage in any cell type at
low TRAIL concentrations. The model predicts that Type II (baseline) and Type I (XIAP
KO and Bcl2 OE XIAP KO) cells die when confronted with moderate concentrations of
TRAIL. These dose-responses were sigmoidal with a lower threshold for TRAIL
sensitivity for XIAP KO cells (0.08 ng/mL) compared to the baseline case (2 ng/mL).
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Figure 4-6 TRAIL dose response in Type I and Type II cells
(A) Hypothetical dose responses for Type I and Type II cells are depicted with MOMP-impaired Type II
cells as outliers. (B-D) Dose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL +
2.5 ;ig/mL CHX at 8h. (B) Simulated cPARP dose responses for the Hctl 16-derived cell lines. (C-D)
Dose responses for Type I and Type II Hct 116 and SKW 6.4 (Type I) cells at 8h cell lines using a two-
color FACS assay for initiator (D) and effector (C) caspase activity (see Methods). % positive is calculated
by gating. The FACS plots with gating and dose response curves for all five cells at .5, 2, 4, and 8h with
and without CHX can be found in the Appendix (Section 6.3.1). The dose responses were measured in two
experiments and data from overlapping experiments were averaged in the curves above (see Appendix
Section 6.3.1).
Initiator and effector caspase-activity was measured by FACS in response to
varying doses responses of TRAIL in the four Hctl 16 cell lines (parental, Bcl2 OE, XIAP
KO, and Bcl2 OE XIAP KO) and in SKW 6.4 cells, B lymphocytes that are prototypical
Type I cells (Section 4.4,[16]). The FACS dot plots and derived dose response curves
following 30m, 2h, 4h, and 8h treatments can be found in the Appendix (Section 6.3.1).
Figure 4-6C shows the dose response curves as the percent of cells that have undergone
PARP cleavage at 8 hours. However, the dose responses matched the model prediction
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with XIAP and Bcl2 OE XIAP KO cells dying above TRAIL concentrations of 0.08
ng/mL. Similarly, the threshold for sensitivity of TRAIL was higher, ~2ng/mL, in
parental Hctl 16 cells as predicted by the model. The dose response in the parental cells
was also less sigmoidal, and fewer than 75% of the cells were cPARP positive at 8 hours
after treatment with 250 ng/mL of TRAIL. As expected, the Bcl2 OE Hctl 16s were
resistant to even high concentrations of TRAIL despite high caspase-8 activity (Figure 4-
6D).
We predicted that the dose response for Type I cells would be easily
distinguishable from the response of MOMP-impaired Type II cells. However, the SKW
6.4 dose response curve was dissimilar to curves from both Hctl 16 parental and XIAP
KO cells. At TRAIL concentrations below 0.4 ng/mL, all five cell types were relatively
insensitive to apoptosis, and Type I and Type II cells were indistinguishable. However,
at moderate doses, it was evident that SKW 6.4 cells tolerated higher doses of TRAIL,
dying above 10 ng/mL (Figure 4-6C). SKW6.4 cells thereby exhibited a dose response
that fell in-between the expected dose responses predicted in Figure 4-6A-B and
measured for Hctl 16-derived cells in Figure 4-6C (see also Figure 6-9). We conclude
that Type I vs. Type II apoptotic behaviors cannot be simply categorized as Type I or
Type II; instead, pathway-usage may be continuous with some cell types exhibiting
intermediate behaviors that are difficult to classify distinctly as Type I or Type II.
Finally, because high caspase-8 activity at the DISC in Type I cells has been
suggested to be the distinguishing factor between Type I and Type II cells [139, 141], we
also measured the dose-response of total caspase-8 activity (not just at the DISC, Figure
4-6D). SKW 6.4 cells actually had a higher TRAIL threshold for caspase-8 activation as
compared to the Hctl 16-derived cells although DISC activation has been measured to be
higher in SKW 6.4 cells [141]. Because we observed Type I behaviors in cells with
lower thresholds for caspase-8 activity (XIAP KO Hctl 16 cells), measuring caspase-8
activation at the DISC may be insufficient for classifying cells, as caspase-8 does not
have to be localized to the DISC to activate caspase-3. We also conclude that because
SKW 6.4 and XIAP KO Hctl 16 cells are Type I yet exhibit different caspase-8 dynamics,
increased activation of caspase-8 at the DISC is not a necessary condition for all Type I
cells.
4.2.4 DLE analysis demarcates Type I, Type II, and variable regions in
phase-space
To understand the multivariate conditions leading to Type I, Type II, or
intermediate Type I/Type II behaviors, we analyzed the model using direct Lyapunov
exponents ([77], Chapter 3, Section 4.4.6). DLEs measure local sensitivity to initial
conditions relative to a finite time. High DLEs define a separatrix, which segregate
phase-space into regions of different qualitative behavior, similar to a bifurcation diagram
for steady-state systems. The model was subjected to a partial DLE analysis, varying
initial conditions of caspsae-8, caspase-6, caspase-3, XIAP, and PARP (Section 4.4.6).
The DLE analysis was performed with a 10-fold increase in Bcl2 concentration to isolate
MOMP-impaired conditions (under baseline Bcl-2 conditions, there is no separatrix
because all "cells" die, not shown). Figure 4-7 (top) shows the 6, 8, and 12h DLEs as a
function of XIAP and caspase-3 concentrations. A clear separatrix (black) separates the
phase-space into two regions based on XIAP and caspase-3 concentration. Above the
separatrix (high caspase-3 and low XIAP concentrations) PARP was cleaved and these
cells were predicted to die despite the Bcl2 OE and are therefore Type I. Below the
separatrix (low caspase-3 and high XIAP concentrations) PARP was not cleaved and
these cells were predicted to be Type II. The separatrix tilted towards the XIAP axis with
time (cells with a higher XIAP/caspase-3 ratio take longer to "die"). Because the
separatrix moved with time, the area between the 6 and 12 hour separatrices defines a
region in which the timing of apoptosis is variable and highly sensitive to initial
concentrations of the network components. The stars indicate the phase-space locations
of Bcl2 OE Hctl 16 (right) and Bcl2 OE XIAP KO Hctl 16 (left) cells. The Bcl2 OE cells
are in the Type II region and the XIAP KO cells are near the separatrix but in the Type I
region, as expected by our experimental observations.
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Figure 4-7 DLE analysis defines Type I ,Type II, and Type I/II variable conditions
A partial DLE analysis of the model shows a separatrix with Bcl2 OE (10-fold increase in Bcl2 initial
concentration). Sensitive regions of phase-space have high DLEs (black) that form a separatrix, separating
phase-space (plotted here in relation to XIAP and caspase-3 concentrations) into two regions. Above the
separatrix, cells die and are Type I. Below the separatrix, cells die and are Type II. The two stars represent
the phase-space locations of Bcl2 OE Hctl 16 cells (right) and Bcl2 OE XIAP KO cells (left). The
separatrix tilts towards the XIAP axis with increasing time, caspase-6 concentration, and DISC activation
rates, indicating that as these factors increase, a larger XIAP/caspase-3 ratio is tolerated for Type I cells.
Together, the separatrices outline a variable Type I/II region which is sensitive to time, caspase-6
concentration, and DISC activation rates. In this variable region, cells are more likely to undergo partial
PARP cleavage.
Caspase-6 amplifies activity in the caspase cascade as an intermediary in the
positive feedback loop that activates caspase-8 via caspase-3 (Figure 4-1). Because
apoptosis in Type I cells is dependent on caspase-3 activation by caspase-8, these cells
are expected to be sensitive to caspase-6 expression. The DLE at different concentrations
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of caspase-6 show that Type I cells with higher XIAP/caspase-3 ratios need more
caspase-6 to remain Type I (Figure 4-7, middle). Accordingly, the separatrix tilted
towards the XIAP axis as caspase-6 concentration was increased. As caspase-6 was
increased, more phase-space was assigned to the Type I region and it became "easier" to
be Type I. This analysis predicts that Type I cells are more sensitive to caspase-6
concentration than Type II cells but caspase-6 expression or activity is not necessary for
all Type I cells.
The rate of DISC formation has been implicated as a distinguishing factor
between Type I and Type II cells. In agreement, our model behaved as a Type I cell
when the rates involved in DISC formation and caspase-8 activation at the DISC were
increased 10-fold (Figure 4-2). To evaluate the role of the rate of DISC activation across
a spectrum of initial concentrations, we computed DLEs at three rates of DISC formation
and activation (Figure 4-7, bottom). As the rate increased, the separatrix swung towards
the XIAP axis, expanding the Type I region at the expense of the Type II region, allowing
cells with low XIAP/caspase-3 ratios to become Type I. As a corollary, high DISC
activation rates were only necessary to achieve Type I behaviors when the XIAP/caspase
was high. At moderate and high rates of DISC formation and activation, simulations at
or near the separatrix stabilized with partial PARP cleavage and the separatrix location
did not shift with time (not shown).
When collated together, the separatrices highlighted three regions: Type I, Type
II, and a Type I/II variable region (Figure 4-7). In the variable region, cells are predicted
to be more sensitive to network and stimulation conditions and have more variable death
times. While caspase-8 activity is necessary for receptor-mediated apoptosis, DLE
102
analysis of the model did not show separatrix sensitivity to caspase-8. Instead, the
separatrix sliced the phase-space into two regions according to caspase-3 and XIAP
concentrations, consistent with our data showing that XIAP depletion can convert Type II
cells into Type I cells. The existence of a variable region implies that Type I/Type II
classifications are continuous, not discrete, and that the ratio of initial conditions of XIAP
to caspase-3 is key in determining which pathways a cell requires for apoptosis.
Consistent with the partial PARP cleavage arising in Bcl2 OE HeLa cells treated with
RNAi against XIAP [142], we observed examples of partial caspase activation (and
PARP cleavage) at initial conditions on separatricies defined by caspase-3 to XIAP
ratios. The mapping of initial concentrations and caspase-8 activation rates at DISC to
apoptotic responses using DLEs enables us to quantitatively evaluate the effects of
network proteins for different cell lines that could be helpful in determining use-cases
and combination therapeutics for TRAIL, Bcl2, and XIAP-targeted cancer drugs.
4.3 Discussion
To understand the regulation of Type I/Type II behavior, we used a systems
approach that combines kinetic modeling and detailed dynamic analysis with quantitative
data of the concentrations and activation kinetics of key proteins. In single cells, we
perturbed the ratios of caspase-3 to XIAP (and ubiquitin-ligase-mutant XIAP) and
observed the kinetics of caspase-3 activity with flow cytometry and FRET-based
reporters in live cell microscopy. We measured the dose response of Hctl 16-derived cell
lines and SKW 6.4 cells and found that loss of XIAP transformed Type II Hctl 16 cells
into Type I cells that displayed caspase-8 and caspase-3 dynamics which differed in
response to varying doses of TRAIL.
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We combined our single-cell data with a Lyapunov exponent-based analysis of a
physicochemical model of caspase-3 regulation to help understand this dynamical
system. Our data and modeling suggest that there is a continuum of Type I/Type II
behaviors and that control of Type I/II apoptosis can occur not only at the level of
initiator caspase activation but at the regulation of effector caspase-activation. We
identified three regions of phase-space that classify cell types within those regions as
Type I, Type II, or Type I/II variable. Cell populations that are in the variable region are
more likely to mixed apoptotic responses, varying with the strength of the pro-death cue
(TRAIL concentration) and the population distributions of XIAP, caspase-3, caspase-6,
and caspase-8 as well as the rate of caspase-8 activation.
By using a systems approach, our study identified a new control point for pathway
usage in apoptosis. Because many tumor cells are sensitive to TRAIL treatment,
understanding the multivariate conditions that confer TRAIL sensitivity and resistance
has clinical relevance [153]. A quantitative identification of the conditions that lead to
Type I or Type II behaviors could be used to identify appropriate therapies for different
tumor types. Our analysis suggests that XIAP-inhibiting drugs (including Smac
mimetics) should more broadly sensitize tumor cells to TRAIL as compared to Bcl2-
targeted drugs (such as ABT-737) which affect only MOMP-protected Type II cells.
[150, 152, 154, 155].
Apoptosis is typically characterized by activation of effector caspases which make
a binary die-or-survive decision. A key feature of apoptosis is the rapid "all-or-nothing"
activation of the caspases. Without this, cells with partial caspase activation may suffer
DNA double strand breaks or other genomic instabilities, potentially leading to
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oncogenesis. If caspases do not become fully active and the cell survives, these genomic
instabilities can potentially lead to oncogenesis. Studies in Albeck et al. [142] and in this
thesis bring light to how this switch-like mechanism operates and breaks down. XIAP is
clearly an important regulator of caspase-3 activity, though the extent and mechanism of
its interactions with caspase-3 and impact on apoptosis is under debate [26, 146, 156,
157]. Our study addresses the effect of XIAP/caspase-3 ratios on the extent of partial
caspase activation. We observed different rates of effector caspase activation in Bcl2 OE
Hctl 16 cells - it will be interesting to quantitatively investigate the relationship between
XIAP concentration and caspase-3 activation. We found partial PARP cleavage in model
simulations of initial conditions that map directly on the separatrix. Therefore, the
separatrix not only delineates conditions leading to Type I and Type II behaviors, but also
defines ratios of caspase-3 to XIAP that may result in partial caspase-activation. The
Type I/II variable phase-space region is the most susceptible to partial-caspase activation
because cells lying in this region are close to separatrix. Because it is rare to find cells
that exhibit this "partial" death behavior, we hypothesize that most cell types tend to
regulate their protein concentrations so that they are squarely in the Type I or Type II
region and far from the variable region and the separatrix.
Interestingly, in the course of building the molecular tools to study the effects of
XIAP expression levels and ubiquitinase activity, we have noticed that XIAP is
extremely difficult to express and therefore appears to be under tight post-transcriptional
regulation. We were surprisingly unable to express untagged-XIAP in cells other than
293T cells. Furthermore, the literature notably lacks documented examples of untagged
XIAP expression in cells other than 293T cells. We observed that large tags at the N-
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terminus of XIAP offered the best protection against XIAP degradation. Similar tight
regulation of other key pro- and anti-apoptotic proteins to preserve set-points may play an
important role in ensuring that cells make the correct apoptotic decision. It remains to be
established whether the reported differential gene regulation in Type I and Type II cells
contributes to stable differences in protein concentration between Type I and Type II
cells [141]. Mapping the locations of several tumor and primary cell lines to the phase-
space may help us to understand if cells gravitate away from the variable regions and to
identify the proteins that are most tightly regulated in this process.
4.4 Materials and Methods
4.4.1 Physicochemical modeling of the apoptosis pathway
The apoptosis signaling model was built and run in Matlab 2007b using the
odel5s solver. This model is a variant of a published model [142] and includes the major
features of both the intrinsic and extrinsic pathways downstream of death receptor
activation. DISC formation is modeled as an activated receptor following ligand binding.
Caspase-8 is activated both at the DISC and by positive feedback from caspase-8 via
caspase-6. Caspase-3 is activated by binding to active caspase-8 but its activity is
inhibited by binding and ubiquitination by XIAP. Attenuation of caspase-8 activity
occurs by competitive binding of FLIP to the DISC and binding of active caspase-8 with
Bar. Crosstalk between the intrinsic and extrinsic pathways first occurs by cleavage of
Bid (to tBid) by active caspase-8. tBid activates Bax and sequesters Bcl2, thereby
changing the ratio of pro- and anti-apoptotic Bcl-2-family proteins at the mitochondria.
Complexes of activated Bax at the mitochondrial outer membrane trigger MOMP and
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subsequent release of cytochrome c and Smac. Cytochrome c forms the apoptosome in
complex with Apaf-1 to activate caspase-9 and Smac then binds to XIAP and. The
intrinsic and extrinsic pathways intersect again at the level of caspase-3 activation by
both caspase-8 and caspase-9. The model contains PARP, a cleavage substrate of
caspase-3. The model includes constitutive synthesis and degradation of all protein
species. Because the model is compared to experiments performed in cells treated with
CHX, the rate of protein synthesis is defined to be low. While the model does not
account for spatial distribution of the species, transport reactions move species between
the cell surface, cytoplasm, and mitochondrial outer-membrane space. We assume well
mixed species within each compartment, see also [44].
The model was reparameterized from the version published for HeLa cells [142]
to parameters better suited for Hctl 16 cells, as described in Section 4.2.1. The kinetic
rate parameters for XIAP binding and ubiquitination of active caspase-3 are described in
Chapter 3.2.1 and [77]. The constitutive degradation rate of active caspase-3 was
increased 5-fold, consistent with experimental data (not shown). To match protein
concentration estimates in Hctl 16 cells, the initial concentration for XIAP was reduced
by 70% to 30,000 molecules per cell and for caspase-3 was increased 10-fold to 100,000
molecules per cell [K. Leitermann, S. Gaudet, P. Sorger, unpublished results].
4.4.2 Cell line derivation and maintenance
Hctl 16 Parental, Bax KO, and XIAP KO cells were gifts from B. Vogelstein and
F. Bunz. Infection with a retrovirus containing puromycin resistant pBabe Bcl2 (a gift
from Joan Brugge's lab) was used to generate Bcl2 OE. The cells were selected with 5
ug/mL of puromycin. For each cell line, a single colony that expressed 10-fold OE of
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Bcl2 was expanded and used unless noted otherwise. Hctl 16-derived cell lines were
maintained in McCoy's media supplemented with 50 units/mL penicillin/streptomycin, 2
mM L-glutamine, and 10% bovine calf serum. SKW 6.4 cells were obtained from ATCC
and were maintained in RPMI supplemented with 50 units/mL penicillin/streptomycin, 2
mM L-glutamine, and 10% bovine calf serum. Three days prior to treatment, Hctl 16
cells were plated at 20,000 cells per well in a 24-well plate. Transient transfection of
mCherry-XIAP and the FRET reporter was performed by standard methods with Fugene
6 (Roche) two days prior to treatment and the media was changed the next day.
Treatments with TRAIL (SuperKiller TRAIL, Alexis Biochemicals), CHX (Sigma-
Aldrich), and MG-132 (Calbiochem) were spiked into wells at a 20x concentrated
mixture. SKW 6.4 cells were plated at a density of 400,000 cells/mL one day before the
time course.
4.4.3 Flow cytometry assay for initiator and effector caspase activity
Following treatment, the floating cells were collected and adherent cells were
trypsinized before undergoing a fixation first in 4% paraformaldehyde in PBS, followed
by methanol. The cells were stored in methanol at -200C for up to a week. Cells were
washed with PBS + .1% Tween-20 and stained for 1 hour with custom Alexa Fluor 488-
conjugated Anti-cleaved PARP (Asp214) monoclonal antibody (BD 624020) and PE-
conjugated anti-cleaved caspase-3 antibody (BD 550914). Single antibody stained
compensation controls were used to establish that compensation was not needed to
distinguish gating for cleaved PARP and caspase-3 (not shown). FACS analysis was
performed using the High Throughput Sampler on a BD LSRII instrument.
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4.4.4 mCherry-XIAP constructs
pExchange-1 -mCherry-XIAP and pExchange- 1-mCherry-XIAPH467A were
constructed by PCR (with the TaqPlus® Precision PCR System, Stratagene) of XIAP and
XIAPH467 from pEBB-XIAP and pEBB-XIAPH467 obtained from Jon Ashwell (via
Addgene.org). mCherry and the XIAPs were ligated into pExchange- l's multiple
cloning site with Not
(5'GCGGCGGCCGCGCCGCCATGGTGAGCAAGGGCGAGGAGGATAACATGGC
C3') and BamH1
(5'GCGGGATCCGCCGCCATGGTGAGCAAGGGCGAGGAGGATAACATGGCC3'
) restriction sites used for mCherry and BamH1
(5'GGCCGGATCCGCCGCCATGACTTTTAACAGTTTTGAAGGATCTAAAACTTG
TGTACCTGC3') and EcoRI
(5'GGCCGAATTCTTAAGACATAAAAATTTTTTGCTTGAAAGTAATGACTGTGT
AGCACATGGG 3') for XIAP.
4.4.5 Effector caspase FRET reporter
Construction and use of the effector caspase FRET reporter is described in
Section 6.4. Cells were tracked by preprocessing the movies in ImageJ to generate a
mask used by a tracking program in Matlab written by Khuloud Jaqaman and Gaudenz
Danuser that was reparameterized to optimally track our Hct 116 cells. Post-processing of
the movies and tracking was performed in Matlab 2007a.
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4.4.6 DLE computation
The partial DLE analysis was performed as described in chapter 3 but the phase-
space region searched was limited to caspase3, caspase8, caspase-6, PARP, and XIAP.
Bcl2 and the DISC activation rates (on-rate of DISC formation, on-rate of DISC
activation, and the on-rate of caspase-8 binding to the active DISC) were variable as
indicated in the text. Initial concentrations for PARP were explored only for 1,000,000
and 1,000,001 because we wanted to include PARP cleavage as a readout for death but
did not intend to evaluate the model sensitivity to PARP concentration. The simulations
and DLEs were computed in Matlab 2007b and were visualized in Spotfire. The code is
available upon request.
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5 Conclusions and Future Directions
5.1 Measuring and modeling intermediate signaling behaviors
The goal of this thesis was to arrive at a more complete understanding of the cell's
death-vs-survival decision by combining quantitative measurement with mathematical
modeling. In attempting both the experiments and the computational modeling and
analysis, it became apparent that our current tools were insufficient to investigate the
"intermediates" (in time and intensity) that pervade cell signaling. We therefore
complemented our study of the cell death decision with the development of methods that
enable us to study these "intermediates".
5.2 Fuzzy logic
A data compendium was gathered by my labmates that documents the
multivariate signaling response in HT-29 colon carcinoma cells to combinations of
saturating, intermediate, and low concentrations of TNF, EGF, and insulin. To interpret
this complex dataset in the context of the vast knowledge of the pathways documented in
the literature, we turned to logic-based modeling, which enables interpretable
documentation of interactions when the network is too large (and unspecified) for ODE-
based modeling. We found that while the literature was rife with "black and white"
descriptions of pathway logic (e.g. activation vs inhibition, on vs off, high or low,
apoptotic or pro-survival, etc.), our data was many shades of "gray". We therefore
modeled the data using fuzzy logic, a mathematical formalism that enabled us to
document and simulate the intermediate "gray" data. Because intermediates levels could
be modeled, we were able to explore kinase pathway crosstalk downstream of three
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cytokines and generate testable predictions about the co-regulation of MEK and MK2 and
the inhibition of IKK signaling from EGF.
The next important step forward will be developing algorithms that can be used to
automatically fit rule weights and membership functions. To do so, a metric must be
designed that measures the goodness of fit between a model and data with penalties for
model complexity. For example, is it preferable to use a discrete three-state model or a
fuzzy two-state model? Measuring model complexity is also challenging and the
difficulties in developing a metric that fairly penalizes different types of parameters is an
open research question. Comparing discrete and fuzzy logic models may provide a
powerful platform to address these questions as the problem contains a variety of
parameters with very different scopes (membership thresholds, rule weights, degrees of
fuzziness, number of memberships, etc.).
5.3 Transient signals and control of the apoptosis decision
We found that transient, intermediate signals played a key role in the apoptotic
signaling network. To quantitatively investigate these pathways experimentally, we
designed single cell assays to measure initiator and effector caspase activation in fixed
cells and a FRET-reporter to measure effector caspase activity by live-cell microscopy.
By using these assays, we found that the classification of cells as Type I or Type II based
on their response to death ligand was not as clear-cut as is currently documented in the
literature. We observed that knockout of XIAP from Type II cells converted the cells to
Type I behavior. Our data contradicts the notion that the difference between Type I and
Type II cells lies in rate of DISC formation. Instead, our data suggest that the
dependency of cells on the mitochondrial pathway for apoptosis also relies on
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downstream components in the signaling network, particularly on the ratio of effector
caspases to XIAP.
We combined our experiments with physicochemical modeling of the apoptotic
signaling network. We found that conventional methods for analyzing the model were
insufficient because the relevant signals were transient, not steady-state. We developed a
new methodology to study transient signals in physicochemical models using direct
finite-time Lyapunov exponents (DLEs). The DLE analysis can identify separatrices
which separate the phase-space into regions having common transient behaviors. Using
this analysis, we outlined regions in phase-space for Type I, Type II, and Type I/II
variable cells depending on the initial concentrations of XIAP, caspase-3, and caspase-6,
and the DISC activation rate. In the Type I/II variable region, increasing caspase-6
concentration and DISC activation rates shifts the separatrix so that higher
XIAP:caspase-3 ratios are permissible for Type I cells. Several improvements over the
DLE analysis methodology can be made and include extending the analysis to rate
parameters (perhaps by introducing place-holding state variables that are proportional to
rates), visualizing not only the DLE values but the identity of the network species that
contributes the most to the change, and scaling the gradients (used to compute the DLE)
relative to the magnitude of each network species.
Our analysis, combined with dose response data in five cell lines, suggests that
rather than discrete distinction between pathways, there is a continuum in the use of
pathways in apoptosis and that there exists a "gray" area where cells sit near the
boundary between Type I and Type II behaviors. In the gray region, cells are expected to
be more likely to undergo partial caspase activation and are highly sensitive to small
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changes in protein concentration in XIAP, caspase-3, and caspase-8. Our quantitative
characterization of determinants of Type I/II behavior may be used to evaluate cases in
which cancer therapeutics involving XIAP, TRAIL, and Bcl2 will be effective.
In searching for determining factors of Type I vs Type II apoptosis, we not only
found that there was a continuum of "typeness" instead of a discrete classification, but
that altering XIAP could convert Type II cells into Type I cells. DLE analysis of the
model revealed that the ratio of XIAP and caspase-3 concentrations is key in determining
whether a MOMP-impaired cell will undergo apoptosis after treatment with TRAIL. We
are currently investigating this ratiometric control experimentally in the Bcl2 OE cells by
measuring the dynamics of caspase-3 activation at different concentrations of XIAP,
XIAPARING, and TRAIL.
5.4 Outlook
In this work, we developed new tools to explore signals in the key "gray" regions
which have been overlooked in conventional studies. By applying these tools to the
survival-vs-death decision, we elucidated crosstalk between kinase pathways and
alternative control mechanisms in apoptotic pathway usage. Our studies highlight the
need to further develop methodology to study intermediate levels of activity and time in
protein signaling. We expect that the success of the systems biology approach will
depend on its ability not only to handle dynamic, multivariate data but to interpret "gray"
signals that act in concert to affect cell behavior.
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6 Appendices
6.1 Supplementary materials for chapter 2
6.1.1 Regulation of IRS-1
IRS-1 is the canonical adapter protein downstream of the insulin receptor, though
some of its many phosphorylation sites are also substrates of other receptor kinases,
including EGFR [94]. In modeling IRS-1 phosphorylation at two sites, tyrosine 896
(IRS(Y)) and serine 636 (IRS(S)), we found that both were regulated by TNF and EGF
but not by insulin (Figure 2-3F and 2-3J). While the FL gates for IRS(S) and IRS(Y) had
the same input variables, the dissimilarity in logic rules revealed differential regulation of
the two phosphorylation sites. Both TNF and EGF treatment positively affect S636
phosphorylation while TNF inhibits EGF-induced phosphorylation at Y896. As outlined
previously [58], serine phosphorylation at 636 is understood to be downstream of insulin-
Akt-mTOR signaling [158, 159]. Surprisingly, our model predicts that IRS(S) is
unaffected by insulin treatment in HT-29 cells. Our prediction supports the hypothesis of
Gaudet et al.: TNF and EGF induce serine 636 phosphorylation through mTOR,
independent of insulin [58]. Further, Gaudet et al. hypothesize that TNF-mediated IRS
phosphorylation at serine 636 inhibits EGF-mediated phosphorylation at tyrosine 896
[58]. In the FL gate for IRS(Y), TNF inhibits EGF-induced IRS(Y) activation, supporting
this prediction.
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6.1.2 ERK and Akt crosstalk
During the formulation of the Akt gate, we included inhibitory crosstalk from
ERK to Akt because it has been observed in several experimental systems [95-97]. The
introduction of crosstalk greatly simplified the rule-base of the Akt gate, suggesting that
this crosstalk exists in the HT-29 cells (Figure 2-31). The mechanism for this crosstalk is
not understood in the literature, and our most effective model includes a short time delay
from ERK to the Akt gate input. Negative crosstalk from the ERK to Akt pathways may
be the mechanism by which TNF inhibits Akt phosphorylation upon insulin treatment, as
observed by Gaudet et al. [58].
6.1.3 Supplementary figures
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Figure 6-1 Differences between logic models
(A) A grid differentiates logic models based on differences in uniqueness of rules and degree of fuzziness
in membership functions. Fuzzy logic (FL) models differ from Boolean logic (BL) and discrete multi-state
logic (DMSL) models because the membership functions are fuzzy and the rule based need not be unique(e.g. more than one rule can fire for a given input state, even when membership to the input states is
discrete). Discrete models (DL) and DMSL models both use discrete membership function but are
different in that DL rule bases allow multiple rules to fire (rules are not unique). Roman numerals I-IV
map the logic rules to figure (C). (B) The truth table for the IRS(S) gate described in Figure 2-2 is
expanded to show the case where multiple rules can fire (DL and FL). IRS(S) output values are in bold.
One value is gray to reflect its rule weight of 0.25. Where more than one output value is shown, both
values result from conflicting firing rules and must be defuzzified. In this case, multiple rule firing results
from non-unique rules (overlapping antecedents), not fuzziness in the membership functions. (C)
Simulations of the IRS(S) across the spectrum of logic gate-types shown and labeled in (A) are shown with
the experimental data (see Figure 2-5A for cytokine conditions).
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Figure 6-2 Non-heatmap representation of the data, FL, and DL models
Simulations from the FL model (green) and DL model (blue) are superimposed on the data (black). Thelayout and conditions are identical to Figure 2-5A.
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Figure 6-3 Degree of fuzziness in a default 3-state FL model
The FL gates described in the main text were built so that only 2-states (2 MFs) were used when possible.
Here, the FL model was built by preferring 3-states per variable. Simulations from 3-state model are
plotted (as compared to the data as shown in Figure 2-5A) for differing degrees of fuzziness [DOFz]. The
discrete 3-state model is more able to reproduce the major feature of the data than the DL 2-state model(Figure 2-5A).
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Figure 6-4 Fitting MK2 rules weights
(A) A heatmap depicts the data, trained and untrained model with 2 MFs (as described in the main text andFigure 2-6), and trained and untrained model with 3 MFs for MK2. (B) The fitted rule weights are plottedfor the model with 2 MFs (see Figure 2-6). (C) The regressed rule weights are plotted for the 36 candidate
rules. The rules are indicated in tabular format; the first two rows describe the state of the inputs, TNF and
time, and the last row is the output MK2 state. L, M, and H represent low, medium, and high states, and Eis the state describing the early response lag. Symbols above the plot show whether the rules were present(V), absent (®), or not applicable (1) in the untrained model. Rules that are different in the trained and
the untrained model have red symbols.
To compare the optimized rule set with our empirically determined set, the bar graph of rule weights was
annotated to indicate discrepancies (red symbols). Seven rules were found to be different, though thedifferences are easiest understood when grouped into three sets. The first set of rules ("a") involve the
antecedent case "If TNF is M and time is L". In the untrained model, the output was M while in the trained
model, the output was L and H (partial). Therefore, the logic for the trained and untrained model was
essentially the same and yielded relatively similar results. In the second set of rules ("b") for the case "IfTNF is H and time if L", the trained model includes additional outputs of M and L (partial) in addition toH, which is the only rule of the set in the untrained model. The third set of rules ("c"), "If TNF is H or M(partial) and time is M, then MK2 is M", was missed when the untrained model was built. In comparing
the heatmaps of the trained to the untrained model when TNF is H or M and time is M, it is apparent thatthe untrained model erroneously omitted these rules (A) and the trained model's rules are improvements
over the untrained model.
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Figure 6-5 Screen shots illustrating FL gate construction
Screen shots depict the simple graphical user interface used to build the model in the Matlab Fuzzy LogicToolbox. (A) In the gate set up window, input and output variables are declared. (B) The MFs can be
changed graphically by choosing different shapes and altering the MF location and slope. (C-D) The rule
editor and viewer is used to write and evaluate rules.
6.2 Supplementary materials for chapter 3
6.2.1 Fixed point criterion
To solve for the fixed points, we note that the listed rate parameters are nonzero.
By definition of a fixed point, we set derivates of each species to zero:
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0 = -kIx 4x 1 + kdlX5
0 = kd2X5 - k3x2x 3 + kd3X6 + kd4X6
o = -k 3x2x3 + kd3x6
0 = kd4x6 - k x4xl + kdlx 5 - k5x7X4 + kd5X8 + kd2x5
0 = -kd 2x 5 + kX4,x 1 - kdlX5
0 = -kd 4X6 + k3x 2x 3 -kd3X6
0 = -ksx 7x4 + kd5x8 + kd6x8
0 = kSX7x4 - kd5X8 - kd6X8
Substituting (17) into (21):
kd2X5 = 0 => x5 = 0.
Substituting (19) and (25) into (18):
kd4X6 = 0 => X6 = 0.
Substituting (25) into (17):
x4 X 1= 0.
Substituting (25), (26), and (27) into (20):
k5x7x4 = kd5X8
Rewriting (24):
ksx7x4 = (kd5 +kd6 )X8 .
Comparing (28) and (29),
(kd5 + kd6)X8 = kd5X8 •
Because we have assumed that the rate constants are nonzero,
Xs =0
Substituting (15) into (12)
x,7 4 = 0
From equations (9), (10), (11), (15), and (16) we can derive steady-state conditions:
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(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
X, = X= X 8 = 0 (33)
x 4 OR(x 1ANDx7) = 0, (34)
x 2ORx3 = 0 (35)
Together, these define conditions for the four types of fixed points in the system (Figure
3-5A).
6.2.2 Determination of stability
The stability of each type of fixed point (listed in Figure 3-5A) was deduced using
conservation relations and type-specific steady state conditions (equations 33-35). This is
convenient since traditional stability analysis would have been extremely difficult for this
8-dimensional system. At each fixed point, there are 2-4 zero eigenvalues, making
stability analysis methods based on linearization inconclusive. The number of zero
eigenvalues was determined symbolically using Maple 9 (Waterloo Maple Inc., Ontario,
Canada).
* Fixed point type 1: All species must have zero concentrations except active caspse-8
and active caspase-3. Since XIAP concentration is zero (there is no turnover of XIAP
in the model and XIAP is not initially present), active caspase-3 cannot form
complexes with XIAP. Therefore, the concentration of caspase-3 and caspase-8 will
not change. These fixed points are unstable because perturbations of XIAP
concentrations to nonzero values send these trajectories to fixed point type 4.
Biologically, these fixed points would represent cells signaling for death because
all of the caspases are active. These fixed points are attracting in some directions
because the pulse peaks approach these fixed points before declining towards fixed
point type 4 (Figure 3-3). In comparing trajectories from above and below the
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separatrix, we noticed that the peak of caspase-3 activation corresponds to this type of
unstable fixed point. The height of the pulse corresponds with its width. For
example, in Figure 3-3C, the active caspase-3 pulse is tall and wide while in Figure 3-
3D, the pulse is short and narrow. The unstable fixed point is attracting in some
directions; therefore, the closer the trajectory moves towards this unstable fixed point,
the stronger the pro-apoptotic pull. This attraction to the unstable fixed point is what
resulted in higher and wider active caspase-3 pulses.
We therefore defined a pulse metric to explore the relationship between the pulse
and the network outcome. Since we hypothesized that the pulse magnitude and width
corresponded with its proximity to these unstable fixed points, we defined a pulse
metric as the shortest distance between the trajectory and fixed point 1. For the time
courses shown in Figures 3-3A-B, the pulse metrics are 1.3 x 104 and 1.4 x 105 for
low and high initial conditions of XIAP, respectively. In Figure 6-6, the pulse metric
is plotted in the same phase-space slice displayed for the DLEs in Figure 3-4A. This
metric divides the phase space similar to the separatrix defined by high DLEs. Above
the separatrix, the pulse metric is small, indicating that those trajectories are strongly
attracted to these fixed points. In being so strongly pulled away from the steady state
by this unstable fixed point, these systems have made a death decision. For the initial
conditions where the pulse metric is large (under the separatrix), the trajectories are
far enough away from the unstable fixed point to avoid being pulled away from the
steady state. As a result, caspase-3 is not strongly activated and these systems avoid
apoptosis.
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* Fixed point type 2: All species must have zero concentrations except caspase-3 and
active caspase-3. Since there is no synthesis of caspase-8 and XIAP in this model
any species containing a form of caspase-8 or XIAP (including all intermediates
complexes) will be absent. These fixed points are unstable because perturbations of
caspase-8 and XIAP concentrations to nonzero values send these trajectories to fixed
point type 4. This type of fixed point would represent an extremely rare (or knock-
out) cell with no caspase-8 or XIAP.
* Fixed point type 3: All species have zero concentrations except caspase-3, caspase-8,
and XIAP. Since there are no active caspases, intermediate complexes cannot be
formed. These fixed points are unstable because perturbations in the active caspases
or intermediate complexes to nonzero values send these trajectories to fixed point
type 4. Biologically, this type of fixed point represents a cell that has not received a
death signal.
* Fixed point type 4: All species have zero concentrations except caspase-8, active
caspase-8, and XIAP. This fixed point is the most general, and almost all biologically
significant initial conditions will fall under this scenario: caspase-8 is converted into
active caspase-8 while caspase-3 is converted into active caspase-3 until XIAP causes
all of the active caspase-3 to be degraded. Given ample time, all of the caspase-3 in
the system is degraded and nonzero concentrations for caspase-8, active caspase-8,
and XIAP may remain. This type of fixed point is stable because under perturbations
to the caspases, intermediate complexes, or XIAP, the network will return to this type
of fixed point. Biologically, this type is fixed point would represent the state of the
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network after it is responded (with a transient behavior) to a death-signal before the
system is reset (not modeled here).
6.2.3 Caspase-3 activation model with protein turnover
Our model was simplified to by omitting protein synthesis and degradation. A
similar analysis was performed with a model extended to include turnover and cleavage
of XIAP by active caspase-3. This extended model yielded similar results to the
simplified model (Figures 6-7 and 6-8). A constitutive degradation rate, kdeg, was
assumed for all species; it was estimated as 4.63 x 10-5 (s') using the half-life of pro-
caspase-3 [160]. The synthesis rate was assumed to be the product of kdeg and the initial
concentration of the protein for pro-caspase-3, pro-caspase-9, and XIAP. The model is
specified below (equations 36-43). The rate of XIAP cleavage by active caspase-3, k,,
is 5 x 10-6 (S-1) [132]. Species numbers and non-turnover parameters are identical to the
basic model described in Figure 3-1 and Table 3-1.
t, = -kx 4XI + kdIX 5 - kdegX i + kdegXl(t = 0) (36)
i2 = kd2x5 - k3x 2x 3 + kd3x 6 + kd4 X6 - kdegX2 (37)
1 3 = -k3 x2x 3 + kd3 6 -k deg X3 + kdeg3 (t = 0) (38)
i4 = kd4X6 - kIX 4 X1 + kdlX5 - k5X7 X4 + kdSX8 + kd2X5 - kdegX 4  (39)
i~ = -kd2 x + kx4XI - kdx 5 - kdeg X5  (40)
X6 = -kd 4x 6 + k 3X2X3 - kd3X6 - kdegX6 (41)
i, = -k 5x7x 4 + kd58x + kd6x 8 - kdegX7 - kciv X 7X 4 + kdegX 7 (t = 0) (42)
is = k5xx 4 - kd5sx - kd6x8 - kdegX8 (43)
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6.2.4 Supplementary figures
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Figure 6-6 A distance metric defines a separatrix
A phase-space subplot of the distance metric (shortest distance to type 1 fixed points) is shown on a linear
scale under the conditions shown for the DLE-defined separatrix in Figure 3-4A The separatrix matching
the DLE-defined separatrix is between small (blue) and large (red) distances. The distance is large below
the separatrix (survival) and small above the separatrix (death).
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Figure 6-7 Time-course simulations show transient death and survival responses under two different
initial conditions of XIAP when turnover is introduced to the model.
In these time courses, the initial conditions matched those in Figure 3-3A-B, respectively. Under a low
initial concentration of XIAP (A), the transient caspase-3 pulse is taller and wider than the pulse under a
higher initial concentration of XIAP.
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Figure 6-8 The six-hour DLE defines a separatrix separating phase-space into pro- and anti-
apoptotic decisions in a model including turnover
The six-hour DLEs are plotted under the conditions in Figure 3-4A. The introduction of protein turnover tothe caspase-3 activation model did not significantly change the shape or the location of the separatrix.
127
I~
e-LI
c
Y
~~-
6.3 Supplementary materials for chapter 4
6.3.1 Supplementary figures
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Figure 6-9 Dose response curves for cleaved caspase-3 and cleaved PARP at .5, 2, 4, and 8 h
Dose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL (and 2.5 jtg/mL CHX as
indicated) are plotted for the four Hctl 16 cell lines and SKW 6.4 as measured with the two-colored FACS
assay for initiator and effector caspase activity (see Section 4.4.3). % positive cleaved caspase-3
(measuring initiator caspase activity) and cleaved PARP (measuring effector caspase activity) is calculated
by gating (see Figures 6-10, 6-11, 6-12, 6-13, and 6-14). The dose responses were measured in two
experiments (the sets are colored by dose in black and gray in Figures 6-10, 6-11, 6-12, 6-13, and 6-14) and
data from overlapping experiments (2 and 50 ng/mL of TRAIL) were averaged in the curves above.
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Figure 6-10 Dose response plots for Hctll6 parental cells at .5, 2, 4 and 8h
Dose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL (and 2.5 tg/mL CHX as
indicated) are plotted with the two-colored FACS assay for initiator and effector caspase activity (see
Section 4.4.3). The measurements were made in two experiments (the sets are colored by dose in black and
gray).
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Figure 6-11 Dose response plots for Bcl2 OE Hctll6 cells at .5, 2, 4, and 8h
Dose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL (and 2.5 ig/mL CHX as
indicated) are plotted with the two-colored FACS assay for initiator and effector caspase activity (see
Section 4.4.3). The measurements were made in two experiments (the sets are colored by dose in black and
gray).
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Figure 6-12 Dose response plots for XIA.P KG Hctll6 cells at .5, 2, 4 and Sb
Dose responses to 0, 0.0032, 0.016. 0.08. 0.4. 2, 10. 50. 250 ng/mL of TRAIL (and 2.5 lig/mL CHX asindicated) are plotted with the two-colored FACS assay for initiator and effector caspase activity (seeSection 4.4.3). The measurements were made in two experiments (the sets are colored by dose in black and
gray). phi,
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Figure 6-12 Dose response plots for XUAP KO Hct116 cells at.5, 2, 4 and 8hDose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL (and 2.5 ýtg/mL CHX asindicated) are plotted with the two-colored FACS assay for initiator and effector caspase activity (seeSection 4.4.3). The measurements were made in two experiments (the sets are colored by dose in black andgray).
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Figure 6-13 Dose response plots for Bcl2 OE XIAP KO Hctll6 cells at .5, 2, 4 and 8h
Dose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL (and 2.5 pg/mL CHX as
indicated) are plotted with the two-colored FACS assay for initiator and effector caspase activity (seeSection 4.4.3). The measurements were made in two experiments (the sets are colored by dose in black and
gray).
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Figure 6-14 Dose response plots for SKW 6.4 cells at .5, 2, 4 and 8h
Dose responses to 0, 0.0032, 0.016, 0.08, 0.4, 2, 10, 50, 250 ng/mL of TRAIL (and 2.5 gig/mL CHX as
indicated) are plotted with the two-colored FACS assay for initiator and effector caspase activity (see
Section 4.4.3). The measurements were made in two experiments (the sets are colored by dose in black and
gray).
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6.4 Quantitative, dynamic measurement of effector caspase activation in
single cells using FRET4
6.4.1 Preface
The all-or-nothing activation of effector caspases, primarily caspase-3, is key in
ensuring that cells make a clear decision to survive or die. To understand the signaling
network regulating this characteristic fast activation which is preceeded by a variable
delay following DISC activation, we require single cell studies that track MOMP, and
initiator and effector caspase activation under different network perturbations. This
section contains excerpts from [142] that pertain to my work building and testing the
effector caspase FRET-based reporter.
6.4.2 Study Abstract
Apoptosis in response to TRAIL or TNF requires the activation of initiator
caspases, which then activate the effector caspases that dismantle cells and cause death.
However, little is known about the dynamics and regulatory logic linking initiators and
effectors. Using a combination of live-cell reporters, flow cytometry, and
immunoblotting, we find that initiator caspases are active during the long and variable
delay that precedes mitochondrial outer membrane permeabilization (MOMP) and
effector caspase activation. When combined with a mathematical model of core
apoptosis pathways, experimental perturbation of regulatory links between initiator and
effector caspases reveals that XIAP and proteasome-dependent degradation of effector
caspases are important in restraining activity during the pre-MOMP delay. We identify
4 This section contains excerpts and figures from 142. Albeck, J.G., et al., Quantitative analysis ofpathways
controlling extrinsic apoptosis in single cells. Mol Cell, 2008. 30(1): p. 11-25.
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conditions in which restraint is impaired, creating a physiologically indeterminate state of
partial cell death with the potential to generate genomic instability. Together, these
findings provide a quantitative picture of caspase regulatory networks and their failure
modes.
6.4.3 Selective live-cell reporters for initiator and effector caspases
To monitor caspase regulation in single living cells, we constructed three
fluorescent protein (FP) fusions (Figure 6-15A, B). The first, effector caspase reporter
protein (EC-RP), monitors caspase-3 activity (and, to a lesser extent, caspase-7 activity)
and is composed of a FOrster resonance energy transfer (FRET) donor-acceptor pair (CFP
and YFP) connected via a flexible linker that contains the caspase cleavage sequence
DEVDR (Figure 6-15B). When the linker is cleaved, energy transfer is lost and the CFP
signal increases, an event that can be monitored by live-cell microscopy. The DEVDR
linker in EC-RP is expected to have 20-fold greater selectivity for caspase-3 relative to
caspase-8 than the DEVDG linker used in previously published caspase reporters [20,
161, 162], based on in vitro data showing DEVDR to reduce kcat/Km for caspase-8 -300-
fold, but keat/Km for caspase-3 only -14-fold relative to DEVDG [163].
Initiator caspase reporter protein (IC-RP) carries tandem copies of IETD in its
linker, a sequence that is efficiently cleaved by caspase-8 [164], but poorly by caspases-
3,7 [165]. IETD constitutes the site in procaspase-3 for initiator caspase cleavage, and
IC-RP cleavage is therefore a good readout of procaspase-3 activation. Finally, a reporter
for MOMP that localizes to the inter-membrane space (IMS-RP) was created by fusing
RFP to the mitochondrial import sequence of Smac (residues 1- 59) [166]. FP fusions to
full-length cytochrome c and Smac have been described previously [7, 167, 168], but
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IMS-RP differs from these fusions in lacking an IAP-binding motif, and it is therefore
biochemically inactive.
To validate the properties of EC-RP, IC-RP, and IMS-RP in vivo, HeLa cells
stably expressing the reporter proteins were treated with TRAIL and cycloheximide
(CHX) and fluorescence signals monitored every 3 min over an 8-12 hr period. IMS-RP
distribution was monitored using an image-processing algorithm that detects shifts from
punctuate mitochondrial to diffuse cytosolic fluorescence. When cells were treated with
varying doses of TRAIL, IMS-RP relocalized at the same time as a co-expressed Smac-
CFP fusion [169] and -6-9 min prior to the appearance of apoptotic cellular morphology
(Figure 6-15C). IMS-RP translocation was blocked in TRAIL-treated cells by RNAi-
mediated depletion of caspase-8 and Bid, upstream components of the extrinsic cell death
pathway, but not by RNAi of downstream components such as Smac (Figure 6-15D).
Thus, IMS-RP appears to be a faithful reporter of protein translocation at MOMP, a
process whose dynamics differs from that of falling mitochondrial membrane potential as
measured using dyes [167].
Caspase-mediated proteolysis of EC-RP and IC-RP was monitored by calculating
the ratio of CFP and YFP emission, with suitable correction for background (see Section
6.4.4). Due to spectral overlap, it was not possible to monitor EC-RP, IC-RP, and IMS-
RP fluorescence simultaneously in single cells, and we therefore expressed the reporters
in pairs. When cells co-expressing EC-RP and IMS-RP were treated with TRAIL,
increases in the CFP/YFP ratio resulting from reporter cleavage were sudden and took
place only after IMS-RP translocation (Figure 6-15E; note that EC-RP signals were
typically lost when cells detached from the slide subsequent to the appearance of
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apoptotic morphology). EC-RP cleavage was reduced 20-fold by RNAi of caspase-8 and
5-fold by RNAi of Bid, consistent with a requirement for MOMP in caspase-3 activation.
Control experiments also established that changes in EC-RP fluorescence required
TRAIL (CHX alone had no effect) and were sequence-specific (being absent with a non-
cleavable DEVG-carrying reporter). However, changes in cell in morphology did alter
apparent FRET signals and were therefore taken into account during image analysis.
Cells co-expressing IC-RP and IMS-RP exhibited gradual increases in IC-RP
signal subsequent to TRAIL treatment, and rapid increases subsequent to MOMP (IMS-
RP release; Figure 6-15F). The early, gradual phase of IC-RP cleavage was insensitive to
Bid depletion but the fast post-MOMP phase was eliminated by it; both were blocked by
depletion of caspase-8. Rapid IC-RP cleavage post-MOMP probably reflects either
elevated caspase-8 activity resulting from feedback via caspase-6 or cleavage by caspase-
9 (RNAi experiments were ambiguous with respect to these possibilities but the IETD
sequence in IC-RP is known to be a good caspase-9 substrate). We therefore conclude
that IC-RP is a selective readout of caspase-8 activity prior to MOMP but is unlikely to
retain this selectivity later on; however, it is complemented by EC-RP, which is the key
readout of the post-MOMP state. Direct comparison with a traditional reporter carrying a
DEVDG caspase-3 recognition sequence further demonstrates the utility of the new EC-
RP reporter: unlike EC-RP, or endogenous caspase substrates (see below), cleavage of
the traditional reporter occurred prior to MOMP (as monitored by IMS-RP release) and
was only partially blocked by Bid depletion (Figure 6-15G).
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Figure 6-15 Live-cell reporters for monitoring extrinsic cell death
In all cases, cells were treated with 50 ng/ml TRAIL+2.5 ýtg/ml CHX. A,B. Schematic diagram of TRAIL-
induced apoptotic pathways and reporter proteins. Abbreviations: ECFP - enhanced cyan fluorescent
protein; Venus - venus yellow fluorescent protein; Sig. seq.- mitochondrial import signal sequence; IBM -IAP-binding motif; mRFP - monomeric red fluorescent protein. C. Kinetics of IMS-RP and Smac-CFP
release from mitochondria. Top: Images from an individual cell expressing both IMS-RP and Smac-CFP
and treated with TRAIL+CHX, at 3 min intervals. Time is relative to the first frame in which IMS-RP and
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Smac-CFP translocation was visible (t--O, pink bar). Bottom: Comparison of IMS-RP and Smac-CFP
localization immediately preceding (t-3 min) and following (t=-0O min) MOMP using an edge detection
filter (see Materials and Methods). D. Percentage of cells exhibiting IMS-RP release when transfected with
control, Bid, caspase-8, or Smac siRNAs and treated for 12 hours with TRAIL+CHX. E,F,G. Timecourses
of cleavage for EC-RP (E), IC-RP (F), or DEVDG-RP (G) imaged in single siRNA-transfected cells treated
with TRAIL+CHX. In cells treated with control siRNA, vertical lines indicate the time of IMS-RP release;
release did not occur in the Bid- and caspase-8-depleted cells.
6.4.4 Materials and Methods
6.4.4.1 Reporter construct
DEVDG-RP was constructed by ligating Venus YFP between BamHI and EcoRI
sites in pECFP-C 1, and ligating linkers encoding cleavage sequences as BspEI-BamHI
fragments between ECFP and Venus. Multiple serine and glycine residues flanking the
cleavage sequences were added to increase linker flexibility and substrate accessibility.
Cell lines and materials HeLa cells were obtained from the ATCC and cultured in
DMEM supplemented with 10% calf serum and L-glutamine; Bcl-2-overexpressing cells
were obtained from Dr. Fei Hua and Dr. Michael Cardone. HeLa cells stably expressing
combinations of EC-RP, IC-RP, and IMS-RP were derived by transfection with Fugene 6
(Roche) and isolation of puromycin and geneticin-resistant colonies. SuperKiller TRAIL
was obtained from Alexis Biochemicals and CHX from Sigma-Aldrich.
6.4.4.2 Live-cell microscopy and image analysis
Time-lapse movies were recorded using a Deltavision-modified Spectris IX71
fluorescence microscope equipped with an environmental chamber (Olympus, Applied
Precision) at 10x or 60x magnification with frames every 3 min. Cells grown in 8-well
chambered cover glass slides (Nunc) were shifted into phenol red-free CO2-independent
medium (Invitrogen) supplemented with 1% fetal bovine serum and L-glutamine for
imaging. For FRET analysis, background-subtracted CFP and YFP images were divided
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to create a ratiometric image using ImageJ and custom plug-ins (available on request).
Signals were normalized by subtracting the minimum value across all time points from
each single-cell time course.
6.4.5 Conclusions
We use live-cell imaging, flow cytometry and mathematical modeling to examine
the states of the core apoptotic network, comprising caspases and their immediate
regulators, in HeLa cells exposed to TRAIL. Single-cell data show that cells treated with
TRAIL enter a state of delay lasting many hours, during which initiator caspases are
active. Because procaspase-3 is a direct substrate of initiator caspases, the enzymatically
active form of caspase-3 is generated steadily throughout the delay state, but its activity is
held fully in check. Previous single-cell experiments examining the dynamics of initiator
and effector caspase activation by death ligands have been contradictory, with the most
recent reports concluding that the two are simultaneous [164, 170, 171]. Our data, based
on improved reporters and quantitative analysis of a large number of cells, demonstrate
that this is not the case. If MOMP is blocked by Bcl-2 overexpression or Bid depletion,
or if TRAIL is added at very low doses, the pre-MOMP delay state can persist with
initiator caspases on and effector caspases off for many hours.
Experiments with proteasome inhibitors strongly suggest that ubiquitin-dependent
degradation of caspase-3 is essential for effective inhibition of its enzymatic activity.
Modeling reveals why this is true: were caspase-3 inhibition dependent solely on XIAP's
activity as a nanomolar competitive inhibitor (IY -1 nM) [172], a >100-fold molar
excess of XIAP over caspase-3 would be required to ensure the highly efficient
inhibition of proteolytic activity observed experimentally in pre-MOMP cells. This arises
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because a competitive inhibitor of an irreversible enzymatic reaction must be present in
large excess to block access of abundant substrates to the enzyme active site [172].
However, XIAP is not present in large molar excess over caspase-3, and available data
suggest that the proteins are present in HeLa cells at roughly similar levels [173].
Conversely, if caspase-3 is modeled as being unstable with a tl/2 of -20 min, active
caspase never accumulates to a high level, and the need for a vast excess of XIAP levels
is reduced. XIAP has an E3 activity, and it is therefore reasonable to model it as having
two activities, one as a competitive inhibitor of caspase-3 catalytic activity and the other
as a mediator of XIAP ubiquitination (although other possibilities can be imagined, and
direct tests with mutant XIAPs remain necessary). It should be noted that even when
both the competitive inhibitory and E3 ligase activities of XIAP are included in our
model, the degree of caspase-3 inhibition observed in pre-MOMP cells is achieved only
with XIAP levels higher than those we estimate by semiquantitative Western blotting
(data not shown). Thus, additional mechanisms of caspase-3 inhibition are required,
among which ubiquitin-independent caspase-3 degradation with a t/ 2 -70 min is one
[144]. Our working model is that three (and possibly more) distinct processes are
involved in restraining caspase-3 catalytic activity during the pre-MOMP delay:
competitive inhibition by XIAP, XIAP E3-mediated destruction by the proteasome, and
ubiquitin-independent proteolysis. Several developmental processes are associated with
procaspase-3 cleavage in the absence of cell death and it will be interesting to ascertain if
similarly complex mechanisms of caspase-3 regulation are involved [174].
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6.5 Quantification of orderliness of kinetochore-kinetochore pairs5
6.5.1 Preface
I have heard more than one applied mathematician joke that the answer to all
problems lies in the singular value decomposition (SVD). The SVD has been extremely
useful in reducing the apparent dimensionality from complex datasets to reveal
similarities and differences amongst data points. This section contains excerpts from
[175] that pertain to my work quantifying orderliness in kinetochore-kinetochore pairs
using the SVD and Shannon entropy. This work highlights the flexibility of SVD in
teasing out dominant trends in data that changes orientation (and number) at each time
step. The Shannon entropy was used to characterize the spread of the singular values
arising from the decomposition. Together, these seemingly irrelevant tools from
mathematical and information theory have enabled us to develop a novel quantification
method for variable, orientation- and point- changing data in cell biology. Without this
methodology, the observed phenotype could not be quantified and critically evaluated.
Because kinetochore biology has not been introduced in this thesis, the introductory
section from the paper is included.
6.5.2 Study Abstract
The correct formation of stable but dynamic links between chromosomes and
spindle microtubules (MTs) is essential for accurate chromosome segregation. However,
the molecular mechanisms by which kinetochores bind MTs and checkpoints monitor this
5 This section contains excerpts and figures from 175. Draviam, V.M., et al., Misorientation and reduced
stretching of aligned sister kinetochores promote chromosome missegregation in EBI- or APC-depleted
cells. Embo J, 2006. 25(12): p. 2814-27.
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binding remain poorly understood. In this paper we analyze the functions of six
kinetochore-bound microtubule-associated proteins (kMAPs) using RNAi, live-cell
microscopy and quantitative image analysis. We find that RNAi-mediated depletion of
two kMAPs, the Adenomatous Polyposis Coli protein (APC) and its binding partner, EB 1
are unusual in affecting the movement and orientation of paired sister chromatids at the
metaphase plate without perturbing kinetochore-MT attachment per se. Quantitative
analysis shows that misorientation phenotypes in metaphase are uniform across
chromatid pairs even though chromosomal loss (CIN) during anaphase is sporadic.
However, errors in kinetochore function generated by APC or EB 1 depletion are detected
poorly if at all by the spindle checkpoint, even though they cause chromosome
missegregation. We propose that impaired EB 1 or APC function generates lesions
invisible to the spindle checkpoint and thereby promotes low levels of CIN expected to
fuel aneuploidy and possibly tumorigenesis.
6.5.3 Introduction
Kinetochores are multi-protein structures that assemble on centromeric DNA and
mediate the attachment of chromosomes to microtubules (MTs). During metaphase, pairs
of sister kinetochores undergo a complex series of movements in which they capture the
plus ends of MTs emanating from centrosomes and also nucleate the formation of MTs
that are guided toward the poles, so as to form stable bipolar attachments to the mitotic
spindle [176]. Following the completion of bipolar attachment by all chromatid pairs, and
the consequent silencing of the Mad and Bub-dependent spindle checkpoint, sister
chromatids disjoin and move towards poles, around which daughter cells form [177]. In
many MT-based processes, motors and MT associated proteins (MAPs) work together to
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regulate MT dynamics in a spatially controlled fashion and to generate forces necessary
for directed movement [178]. Thus, the establishment of bipolarity is thought to depend
on the capture of MTs by kinetochores and the subsequent regulation of MT +end
polymer dynamics by MAPs and motors.
A critical question in the study of mitosis is determining why CIN and aneuploidy
are more frequent in tumor cells than in normal cells [179]. The process of MT capture
by kinetochores is stochastic and therefore takes different lengths of time in different
cells. The function of the spindle checkpoint is to monitor the capture process in each cell
and ensure that anaphase is not initiated until all sister kinetochore pairs are correctly
MT-bound. Thus one possible cause of CIN is that checkpoint pathways are not
functional in tumor cells. However, while CIN is observed in yeast carrying mutations in
either checkpoint or kinetochore genes [180] analogous mutations in human cells cause
mitotic catastrophe and cell death [181]. Thus, it is not surprising that only few human
tumors have been found to harbor mutations in Mad and Bub spindle checkpoint genes
[182, 183]. In contrast to checkpoint and inner kinetochore proteins, outer kinetochore
components are attractive as genes whose disruption might impair chromosome-MT
attachment while leaving the checkpoint intact [184, 185]; VMD and PKS, unpublished
results). Chronic disregulation of kMAP function might have similar effects as low doses
of anti-MT drugs such as taxol and the vinca alkaloids, which cause CIN in some cells
[186].
Previous work in a variety of eukaryotes has identified many MAPs that localize
to kinetochores [187]. The Dynein-Dynactin motor complex and the +end binding
proteins CLIP 170 and LIS 1 accumulate on kinetochores that are unattached to MTs [188,
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189]. In contrast, EB 1 is recruited selectively to kinetochores that are associated with
growing MTs [190] and Adenomatous Polyposis Coli protein (APC), an EB 1 binding
protein is enriched on kinetochores bound to MTs [191, 192]. Finally, CLASP localizes
to kinetochores regardless of MT-attachment status [193]. CLASP1 and CLIP170
regulate kinetochore-MT binding in distinct ways: CLASP 1 controls MT dynamics at
attached kinetochores [194, 195] while CLIP170 is involved in MT capture [196]. As
expected, depletion of CLIP170 or CLASP1 interferes with bipolar MT binding and
causes cells to arrest in mitosis in a checkpoint-dependent fashion [195, 196]. In the case
of Dynein or LIS 1, published data are contradictory with respect to function in mitosis
and MT binding [189, 197-200]. Depletion of the EB 1 or APC kMAPs has been reported
to cause chromosome misalignment and missegregation[192, 200], implying a defect in
the checkpoint response, but it is unknown why APC and EB 1 depleted cells divide
rather than arrest when misaligned chromosomes are present.
In this paper, we study the effects of disrupting proteins at the kinetochore-MT
interface on the generation of CIN in human cells. We use live-cell microscopy and
quantitative image analysis to compare directly the fates of mitotic cells that have been
depleted of one of six kMAPs by RNAi. We find that depletion of CLIP 170, Dynein
heavy chain (DHC), LIS 1 or chTOG1 prevents normal chromosome congression and
results in prolonged checkpoint-dependent mitotic arrest, eventually leading to cell death.
In contrast, depletion of EB 1 or APC does not significantly interfere with congression but
prevents the formation of an ordered metaphase plate. This leads to sporadic chromosome
missegregation at anaphase. The lesions induced by EB 1 or APC loss are sensed poorly if
at all by the spindle checkpoint but the checkpoint itself is still functional. We speculate
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that sporadic missegregation of chromosomes in EB 1- or APC-depleted cells represents a
type of CIN that might fuel tumorigenesis.
6.5.4 Disordered metaphase plate in EB1- and APC-depleted cells
Although chromosomes congressed to the spindle equator in EB 1- or APC-
depleted cells, metaphase plates were less compact than in control cells. To quantify the
degree of order in the metaphase plate, the rotational angles of k-k axes (line connecting
sister kinetochores defining kinetochore orientation) was determined for multiple
kinetochores per spindle by examining 3D images of cells expressing the kinetochore
marker CENPB-GFP. Typically, 12-18 k-k axes could be distinguished clearly per cell
per time point in the 6min preceding anaphase. The angles describing each set of k-k axes
(a0 l,P1l,y; a2,• 2 ,y2; ...) were then transformed by singular value decomposition (SVD) into a
new set of optimal angles (al',Pl',yl'; aI,52',Y2';2,...) and singular values (SVs; 01a,2,03)
(Figure 6-16A). Under normal circumstances, MTs exert pulling forces on bioriented
kinetochore pairs causing them to line up in an ordered metaphase with their k-k axes
oriented parallel to each other and to the spindle axis (Figure 6-16B). A set of ordered k-k
axes has one high, and two low SVs (Figure 6-16A, left) whereas a set of disordered axes
has more than one high SV (Figure 6-16A, right). The overall extent of disorder can be
captured by the Shannon entropy, which varies from 0, representing perfect order, to 1,
representing complete disorder (Figure 6-16B and see Methods). Importantly, SVD is
robust to variability in the number of measurements and is unaffected by large and rapid
rotations in the spindle axis, such as those induced by EB 1 and APC depletion.
When the Shannon entropy associated with k-k axis orientations was quantified in
individual EB -, APC- or control-depleted cells over a 6min period prior to anaphase
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onset, a striking result was obtained. In control cells, the Shannon entropy started out
relatively high (0.68 ± 0.15) but fell rapidly (to 0.03 + 0.07) 1.5min before anaphase
onset (Figure 6-16C). In contrast, in EB 1- or APC-depleted cells, the Shannon entropy
was high throughout the observation period, remaining as high at -1.5min as at -6min (0.6
to 0.7; Figure 6-16C). In principle, high Shannon entropies might reflect severe
misorientation of a few sisters or widespread disorder involving many sisters (Figure 6-
16A). To distinguish among these two extremes we plotted the SVs for individual k-k
axes over time. In control cells, only two or three sisters had axes pointing away from the
most probable direction by t= -3min (Figure 6-16D). All of these misorientations were
resolved in the minute or two before anaphase onset. In EB 1- or APC-depleted cells, in
contrast, disorderliness was distributed more or less uniformly across kinetochore pairs
and remained high as metaphase proceeded (Figure 6-16E and 6-16F). The difference
between control and APC-depleted cells was highly significant (p=0.008 as estimated
using K-Annova) as was the difference between control and EB 1-depleted cells
(p=0.004); however, EB 1 and APC depletions (p=0.87) were indistinguishable. We
therefore conclude that high Shannon entropy in k-k axes in EB 1 and APC depleted cells
is due to extensive misorientation involving many sister chromatids.
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Figure 6-16 EB1 or APC depletions perturb orientation of centromeric pairs
(A) Schematic representation of three distinct states of k-k axes orderliness. Orthogonal lines indicate
orientations of the original coordinate system a, 0, y (grey) and new optimized directions a',Pj',y' (blue,
green, red). Bar graphs show the contribution of each of the five k-k axes to the optimized directions. Plots
below indicate singular values (SV) in three directions (a l,a 2,o3). (B) Schematic representation of
disorderliness in k-k axes of congressed kinetochores. Shannon entropy values for a state of complete
disorderliness =1 and orderliness =0 (C) Shannon entropy of 10-15 k-k axes calculated in each of 5 cells for
a 6min period prior to anaphase onset. Cells were transfected with control, EB I or APC siRNA oligos as
indicated. (D-F) Graphs indicate contribution of individual k-k axes to optimized direction in cells treated
with siRNA against control (D), APC (E) or EB 1 (F) calculated from 3D-images taken every 90sec for a
6min period prior to anaphase. Upper panel indicate Ui1 for individual k-k axis. Lower panels indicate SV
(al,a2,a3). S indicates Shannon entropy value.
6.5.5 Chromosome missegregation following EB1 and APC depletion
When the Shannon entropy associated with k-k axes was plotted against the
number of lagging chromosomes on a cell-to-cell basis, a strong positive correlation was
observed (Figure 6-17A): the greater the entropy, the larger the number of lagging
chromosomes. Thus, disorder in the alignment of kinetochore pairs on the metaphase
plate was closely associated with chromosome missegregation in anaphase. It was
striking, however, that most sister kinetochores were unstretched and misoriented
following EB 1 or APC depletion but only a few subsequently missegregated in anaphase.
To investigate the relationship between disorder in the metaphase plate and non-
disjunction we attempted to follow individual kinetochore pairs immediately before and
after anaphase. In HeLa cells, chromosomes are crowded at the spindle equator and
tracking individual kinetochores is technically challenging. However, in four EB 1-
depleted cells and five APC-depleted cells from four independent experiments, it was
possible to trace the kinetochores of lagging chromosomes in anaphase to kinetochore
pairs displaying a high degree of k-k axis misorientation late in metaphase (Figure 6-17B
and 6-17C). When lagging kinetochores were followed through to telophase, it was also
apparent that laggards were incorrectly assorted among daughter cells; unseparated
kinetochore pairs were segregated as a set into one daughter cell (Figure 6-17D). Despite
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a strong association between metaphase misalignment and lagging kinetochores and
between lagging kinetochores and non-disjunction, it is significant that many sister
kinetochores with misoriented k-k axes disjoined normally. Thus, EB I1 and APC
depletion cause highly penetrant problems with orientation and stretching of kinetochore
pairs but a particular kinetochore pair in a single cell still has only a low probability of
being missegregated.
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Figure 6-17 Misoriented centromeres lag in anaphase and undergo missegregation
(A) Plot of Shannon entropy values associated with k-k axis orientation in single siRNA-treated cells 90sec
prior to anaphase and the number of lagging chromosomes that appeared subsequently in anaphase. (B)
Rendered images of 5um thick section acquired every 90sec in a CENPB-GFP expressing cell treated with
EB 1 siRNA. Orange arrows mark lagging centromeres. (C) 3X-enlarged image details k-k axes (red) with
bold lines projected out of plane and thin lines parallel to plane. Bar graph shows the contribution of
individual k-k axis to optimized direction at t=4:30min; S indicates Shannon entropy value. (D) Rendered
images of 5pm thick section acquired every 3min in a CENPB-GFP expressing cell treated with EB 1
siRNA (orange and red arrows mark lagging kinetochores). Far right panel is 0:6:82 -rotated and 8X
enlarged; arrows mark unseparated pair. lunit=-3um.
6.5.6 Methods: Quantification of k-k axes disorderliness
Rotation angles (oa,3,y) of k-k axes were obtained from each cell at discrete times
using SoftWorx. Sets of angles for n k-k axes were arranged into matrix A (nx3). svd
function in MATLAB was used to compute singular value decomposition (SVD) of
A= UIVT where U and V are orthogonal and E is diagonal of singular values (61,62,G3).
SV describes degree of variation in the angles along each direction in V (ct',P,y').
Shannon entropy of the SV [201] is defined as
1 3
-1 Pi log(pi)
log(L) i=1
where
2
'-3Pi~ i
J=1
6.5.7 Conclusions: Defects in metaphase plate dynamics caused by EBI or
APC depletion
Although chromosomes in EB - or APC-depleted cells congressed to the spindle
equator, two defects in the resulting metaphase plate were evident: kinetochore pairs did
not orient in an orderly fashion and they were not fully stretched. In control cells, most
152
kinetochore pairs aligned early in metaphase perpendicular to the spindle equator and
oriented parallel to each other. The completion of congression manifested itself as a
decrease in the entropy of k-k axis orientations. Concomitantly, inter-kinetochore
stretching increased such that all centromere pairs were stretched by the time anaphase
was initiated. The ordered orientation and stretching of centromeres are almost certainly
linked: stretching reflects the imposition of pulling forces on pairs of sisters following bi-
orientation and causes k-k axes to align parallel to the spindle axis, and thus to each
other. In EB 1- or APC-depleted cells, in contrast, centromeres do not stretch normally
and k-k axes point in different directions. The similarity between EB 1 and APC depletion
phenotypes suggests that interaction of the two proteins might be important. EB 1 C-
terminus contains APC-binding site and also the sites for binding to other k-MAPs,
including pl50Glued, CLIP-170 and CLASP1. However, pl50Glued, CLIP-170 whereas
EBi and APC are present until anaphase ([188, 193]; VMD and PKS, unpublished data).
EB1 and APC localize in a MT-dependent fashion whereas CLASP1 associates early on
with kinetochore in a MT-independent fashion [193]. Thus, anaphase defects observed in
cells expressing an EB 1 C-terminal deletion mutant probably reflect a dominant negative
effect on APC -EB 1 binding.
What prevents kinetochore from becoming stretched and ordered at the metaphase
plate in EB - and APC-depleted cells? One possibility is kMT +end dynamics are
disrupted. EB 1 is shown to stabilize MT +ends and to accumulate on kinetochores
attached to growing MTs [190]. Mutations in APC that disrupt APC-EB 1 interaction are
reported to increase the frequency of pausing between periods of MT +end growth and
shrinkage [200]. In EB 1- or APC-depleted cells, an increased incidence of +end pausing
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would perturb the oscillation of sisters along the spindle axis and potentially cause
kinetochores to remain unstretched. Reduced stretching would then interfere with the
establishment of a preferred k-k orientation. Finally, errors in orientation would give rise
to a less compact and staggered metaphase plate, subsequently predisposing cells to
missegregation.
6.6 Abbreviations
AIF - apoptosis inducing factor
APC - Adenomatous Polyposis Coli
BL - Boolean logic
c3 - caspase-3
c8 - caspase-8
cc3, c3* - cleaved caspase-3, *=active form
cc8, c8* - cleaved caspase-8, * = active form
CIN - chromosomal loss
cPARP - cleaved PARP
CSR - cue-signal-response
DISC - death-inducing signaling complex
DL - discrete logic
DLE - direct finite-time Lyapunov exponent
DOF - degree of firing
DOM - degree of membership
EGF - epidermal growth factor
ERK - extracellular signal-regulated kinase
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FACS - fluorescence-activated cell sorting
FKHR - Forkhead transcription facto
FL - fuzzy logic
FRET - Forster (or fluorescence) resonance energy transfer
IKB - inhibitor of NF-cB
IKK - IrB kinase
IL-la - interleukin-la
IRS-1- insulin receptor substrate-i
JNK - c-jun N-terminal kinase
KO - knockout
MAPs - microtubules associated proteins
MAPK - mitogen-activated protein kinase
MAPKK - mitogen-activated protein kinase kinase
MAPKKK - mitogen-activated protein kinase kinase kinase
MEK - MAP extracellular signal-regulated kinase kinase
MF - membership function
MK - MAPK-activated protein kinase
MK2 - mitogen-activated protein kinase-activated protein kinase 2
MOMP - mitochondrial outer membrane permeabilization
mTOR - mammalian target of rapamycin
MTs - microtubules
NF-KB - nuclear factor K B
NSAID - non-steroidal anti-inflammatory drug
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ODE - ordinary differential equation
OE - overexpressing
PARP - Poly ADP ribose polymerase
PCA - principal component analysis
PDE - partial differential equation
PLSR - partial least-squares regression
ProC3 - pro-caspase-3
SVD - singular value decomposition
TGF a - transforming growth factor a
TNF - tumor necrosis factor a
TRAIL - tumor necrosis factor-related apoptosis-inducing ligand
XIAP - X-linked inhibitor of apoptosis
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